Relationship of Catecholamines and Glucocorticoids to Lymphoproliferation of Equine Peripheral Blood Mononuclear Cells. by Potla, Lavanya
Louisiana State University
LSU Digital Commons
LSU Historical Dissertations and Theses Graduate School
1996
Relationship of Catecholamines and
Glucocorticoids to Lymphoproliferation of Equine
Peripheral Blood Mononuclear Cells.
Lavanya Potla
Louisiana State University and Agricultural & Mechanical College
Follow this and additional works at: https://digitalcommons.lsu.edu/gradschool_disstheses
This Dissertation is brought to you for free and open access by the Graduate School at LSU Digital Commons. It has been accepted for inclusion in
LSU Historical Dissertations and Theses by an authorized administrator of LSU Digital Commons. For more information, please contact
gradetd@lsu.edu.
Recommended Citation
Potla, Lavanya, "Relationship of Catecholamines and Glucocorticoids to Lymphoproliferation of Equine Peripheral Blood
Mononuclear Cells." (1996). LSU Historical Dissertations and Theses. 6274.
https://digitalcommons.lsu.edu/gradschool_disstheses/6274
INFORMATION TO USERS
This manuscript has been reproduced from the microfilm master. U M I 
films the text directly from the original or copy submitted. Thus, some 
thesis and dissertation copies are in typewriter free, while others may be 
from any type o f computer printer.
The quality of this reproduction is dependent upon the quality of the 
copy submitted. Broken or indistinct print, colored or poor quality 
illustrations and photographs, print bleedthrough, substandard margins, 
and improper alignment can adversely affect reproduction.
In the unlikely event that the author did not send UMI a complete 
manuscript and there are missing pages, these will be noted. Also, if  
unauthorized copyright material had to be removed, a note will indicate 
the deletion.
Oversize materials (e.g., maps, drawings, charts) are reproduced by 
sectioning the original, beginning at the upper left-hand com er and 
continuing from left to right in equal sections with small overlaps. Each 
original is also photographed in one exposure and is included in reduced 
form at the back o f the book.
Photographs included in the original manuscript have been reproduced 
xerographically in this copy. Higher quality 6” x 9” black and white 
photographic prints are available for any photographs or illustrations 
appearing in this copy for an additional charge. Contact UMI directly to 
order.
UMI
A Bell & Howell Information Company 
300 North Zeeb Road, Ann Arbor MI 48106-1346 USA 
313/761-4700 800/521-0600
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
R e p r o d u c e d  with pe rmiss ion  of  the  copyright  owner .  Fur the r  reproduct ion  prohibi ted wi thout  permiss ion .
RE LA i lONSHIF OF CATEi^nOLAMINtS AND GLUCOCOR i iCOIDS TO 
LYMPHOPROLEFERATION OF EQUINE PERIPHERAL BLOOD 
MONONUCLEAR CELLS
A Dissertation
Submitted to the Graduate Faculty o f the 
Louisiana State University and 
Agricultural and Mechanical College 
in partial fulfillment o f the 
requirements for the degree of 
Doctor o f Philosophy
in
The Interdepartmental Program in 
Veterinary Medical Sciences 
through the Department o f 
Veterinary Microbiology and Parasitology
by
Lavanya Potla
B.V.Sc & A.H., Andhra Pradesh Agricultural University, 1991
August 1996
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
UMI Number: 9706357
UMI Microform 9706357 
Copyright 1996, by UMI Company. All rights reserved.
This microform edition is protected against unauthorized 
copying under Title 17, United States Code.
UMI
300 North Zeeb Road 
Ann Arbor, MI 48103
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
ACKNOWLEDGMENTS
I wouid iike to thank my committee members, Drs. D.W. Horohov, S.G. 
Kamerling, K.L. O'Reilly, and J. Storz for their invaluable time, constructive criticism, 
timely encouragement, and helpful recommendations. I sincerely thank collaborators Drs.
D.W. Horohov, D.D. French, and S.G. Kamerling, for their efforts towards the successful 
completion o f this research project.
My special thanks is extended to my major professor and advisor. Dr. P. A. 
Melrose, for her advice and guidance in structuring and developing this research project. I 
would also like to extend my special appreciation to her for introducing me to the 
scientific community.
I am grateful to Ms. Susan Pourciau, Mr. Michael L. Keowen, and Dr. B. Toth, 
for their technical support. I would also like to thank Dr. S. Barker for providing HPLC 
facilities for the research, Dr. M.A. Littlefield-Chabaud for her help in sample collection, 
Mr. Michael Kearny for his support in statistical analysis, and Dr. W.G. Henk for 
providing lab space.
I am thankful to the Department o f Veterinary Anatomy and Cell Biology and the 
School o f Veterinary Medicine for providing me with financial assistance. I will always be 
indebted to my colleagues and friends for the inspiring and friendly atmosphere they 
created. On the same note, I would like to thank my colleagues Dr. Jing Bu, Ms. Cynthia 
Pickel, and Mr. Chris Meseke; my friends Ms. Daisy Goynes, Dr. Geetha Satteneni, Ms.
ii
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Cindy Daigle, Ms. Virginia Duncun, Dr. Poomi Iyer, Dr. Sudhir Das Prayaga, Mr. 
Raghuram, Ms. Apama Abburi, and Ms. Sukhanya Jayachandra.
Special thanks to my husband, Madhava, for his patience and loving support that 1 
have enjoyed all through this pursuit. I thank my family, Mr. Kishore Reddy, Mrs. 
Radhika Reddy, and Mr. Mahendra Reddy for their unending support in all endeavors. 
This dissertation is dedicated to my mother, Mrs. Rajya Lakshmi Potla, and my father, Dr. 
Linga Reddy Potla, whose eternal love and sacrifice have opened avenues for 
opportunities that I have gratefully enjoyed throughout my life.
iii
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
TABLE OF CONTENTS
ACKNOW LEDGM ENTS...........................................................................................................ii
LIST OF TABLES ...............................................................................................................  viii
LIST OF FIG U R ES.................................................................................................................  ix
LIST OF ABBREV IATIO N S....................................................................................................x
A B ST R A C T ............................................................................................................................... xii
CHAPTER I INTRODUCTION.............................................................................. 1
II LITERATURE R E V IE W .................................................................... 4
A. Anatomical relays involved in the stress response . . . .  4
1. Hypothalamo-pituitary-adrenal a x is .................... 4
2. Autonomic nervous system innervation o f 
lymphoid tis su e ...................................................... 8
B. Biological significance o f  stress ..................................... 13
C. Neuroendocrine-immune interactions.........................  15
1. Glucocorticoids and the immune system . . . .  17
2. Catecholamines and the immune system . . . .  21
D. Infection and disease potential of stress..... ....................26
E. Influenza in fec tio n ........................................................... 29
1. Biology o f influenza v iru s .................................. 29
2. Immune response to influenza virus infection . 30
a. Humoral immunity.................................. 30
b. Cellular immunity .................................. 32
3. Equine in fluenza ..................................................32
a. Clinical s ig n s ........................................... 34
b. V accination............................................. 34
4. Lymphoproiiferative response to vaccination 
and infection .........................................................35
F. Effects of exercise stress on humoral and cellular 
immunity ........................................................................... 37
G. Closing remarks ................................................................39
III MATERIALS AND METHODS ....................................................41




Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
B. Blood sample collection and analysis ........................... 47
1. Immunological a s sa y s ......................................... 47
a. Recovery o f PBMCs ..............................48
b. Mitogen-induced 
iymphoproliferation................................48
c. Equine influenza virus-specific 
Iymphoproliferation................................49
2. Hormone assays .................................................. 49
a. Cortisol radioimmunoassay .................. 50
b. Catecholamine assay ..............................51
C. Statistical analysis ........................................................... 52
IV DIURNAL CHANGES IN SPECIFIC BINDING OF CORTISOL 
TO CYTOSOLIC AND NUCLEAR FRACTIONS FROM 
EQUINE PERIPHERAL BLOOD MONONUCLEAR CELLS . 53
A. Introduction.......................................................................53
B. Materials and methods .................................................. 54
1. Horses .................................................................. 54
2. Sample collection and fractionization of 
nuclear and cytosolic p ro te in ..............................55
a. Sample collection.....................................55
b. Fractionization of nuclear and cytosolic 
protein .....................................................55
3. Validation of receptor binding assays ..............56
a. Time-dependent specific binding of 
radiolabeled cortisol to cytosolic 
preparations .......................................  56
b. Saturation o f specific binding with 
variable radioligand concentrations . . 57
c. Linear binding to different protein 
concentrations......................................... 57
d. Loss o f specific binding in heat-treated 
sam ples.....................................................5S
4. Diurnal variation o f cortisol binding to nuclear 
and cytosolic fractions......................................... 5S
C. R esults................................................................................58
D. D iscussion.........................................................................64
V RELATIONSHIP BETWEEN EXERCISE-STRESS-INDUCED 
CHANGES IN LYMPHOPROLEFERATION AND 
CIRCULATING CATECHOLAMINE CONCENTRATIONS
IN H O R SE S.........................................................................................67
A. Introduction......................................................................67
v
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
B. Materials and m ethods........................................... 69
1. Horses ................................................................69
2. Stress test regimes ........................................... 69
3. Sample collection, catecholamine 
quantification, and Iymphoproliferation assays 69
4. Statistical analysis............................................. 70
C........................Results.........................................................70
1. Circulating concentrations o f catecholamines
in different stress te s ts .......................................70
2. ElV-specific and mitogen-induced 
Iymphoproliferation........................................... 72
3. Relationship o f catecholamine concentrations to 
influenza-specific and mitogen-induced 
Iymphoproliferation for samples collected 
during the five different stress t e s t s ................ 74
D. D iscussion..................................................... 74
VI CATECHOLAMINES MAY ACT THROUGH BETA 
ADRENERGIC RECEPTORS TO EFFECT 
LYMPHOPROLEFERATION OF EQUINE PERIPHERAL 
BLOOD MONONUCLEAR C E L L S ........................................... 79
A. Introduction.................................................................... 79
B. Materials and m ethods.................................................. 80
1. Horses ................................................................80
2. Preparation o f compounds ..............................80
3. Sample collection and Iymphoproliferation 
assays ................................................................81
4. Statistical analysis............................................. 81
C. Results............................................................................. 81
1. Effects o f norepinephrine on 
Iymphoproliferation o f PBMCs cultured for 5 
days .................................................................... 81
2. Effects o f epinephrine on Iymphoproliferation
o f PBMCs cultured for 5 d a y s ......................... 83
3. Effects o f alpha-adrenergic agonist on 
Iymphoproliferation of PBMCs cultured for 5 
days .................................................................... 83
4. Effects o f beta-adrenergic agonist on 




Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
VII RELATIONSHIP BETWEEN EXERCISE STRESS-INDUCED
CHANGES IN LYMPHOPROLIFERATION AND 
CIRCULATING CORTISOL CONCENTRATIONS IN 
P O N IE S ................................................................................................89
A. Introduction......................................................................89
B. Materials and m ethods................................................... 89
1. P o n ies...................................................................89
2. Stress test regimes ............................................90
a. Acclimation periods................................ 90
b. Stress tests ............................................. 92
3. Sample collection and analysis.......................... 94
4. Statistical analysis.............................................. 95
C. R esults...............................................................................95
1. Baseline cortisol concentrations and EIV- 
specific and mitogen-induced 
Iymphoproliferation............................................. 95
2. Effect o f minimal exercise stress on circulating 
cortisol concentrations and 
Iymphoproliferation............................................. 98
3. Effect o f slow gallop/moderate exercise stress 
on circulating cortisol concentrations and 
Iymphoproliferation............................................. 98
4. Effect o f fast gallop/intense exercise stress on 
circulating cortisol concentrations and 
Iymphoproliferation......................................... 103
5. Quantitation o f catecholamines in samples 
collected during the three different stress
tests ..................................................................  103
6. Relationship o f circulating cortisol 
concentrations to Iymphoproliferation of 
PBMCs collected from ponies........................  106
D. Discussion..................................................................................... 106
VIII SUMMARY AND PERSPECTIVES OF THOUGHT FOR FUTURE
RESEARCH ................................................................................................ 109
R EFER EN C ES......................................................................................................................  115
VITA ......................................................................................................................................  134
vii
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
LIST OF TABLES
1. Age, sex, and order of experimental procedures performed on h o rs e s ........................ 43
2. Dales and Ihe specific horses used in each stress te s t ......................................................46
3. Specific binding of radiolabeled cortisol to PBMC fractions collected throughout
the d a y ................................................................................................................................... 63
4. Physiological concentrations o f amines in resting and stressed horses ........................ 71
5. Lymphoproliferative response o f PBMCs collected during different stress tests . . . .  73
6. Dates for vaccination, stress tests, and acclimation p e rio d s .......................................... 91
7. Cortisol concentrations in resting p o n ie s .......................................................................... 96
8. Lymphoproliferation of PBMCs collected from resting ponies......................................97
9. Cortisol concentrations in ponies exposed to minimal exercise s tre ss .......................... 99
10. ElV-specific and mitogen-induced lymphoproliferation o f PBMCs collected from 
ponies exposed to minimal exercise s tre s s ..................................................................  100
11. Cortisol concentrations in ponies exposed to slow gallop/moderate exercise
stress ...............................................................................................................................  101
12. ElV-specific and mitogen-induced lymphoproliferation in ponies exposed to slow 
gallop/moderate exercise s tre ss ....................................................................................  102
13. Cortisol concentrations in ponies exposed to fast gallop/intense exercise stress . .  104
14. ElV-specific and mitogen-induced lymphoproliferation in ponies exposed to fast 
gallop/intense exercise stress.........................................................................................  105
viii
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
LIST OF FIGURES
1. Hypothalamo-pituitary-adrenal axis and feedback c o n tro l...............................................7
2. ANS innervation o f  lymphoid tissue ................................................................................... 9
3. Factors which modify the effects o f a stressor on activation of the HP A axis and the 
A N S .........................................................................................................................................14
4. Pathways involved in the interactions between the nervous and immune systems . . .  16
5. Receptor mediated genomic actions of glucocorticoids.................................................20
6. Proposed mechanisms for P-adrenergic effects on T cell activation ............................ 25
7. Time dependent binding of radioactive cortisol to PBMC frac tions ............................ 60
8. Linear binding of radiolabeled cortisol to PBMC fractions ......................................61
9. Saturable specific binding o f cortisol to PBMC fractions.............................................. 62
10. Effects o f norepinephrine (NE) on lymphoproliferation o f PBMCs cultured for
5 days ....................................................................................................................................82
11. Effects o f epinephrine (E) on lymphoproliferation o f PBMCs cultured for 5 days . 84
12. Effects o f alpha-adrenergic agonist on lymphoproliferation of PBMCs cultured
for 5 days .............................................................................................................................85
13. Effects o f beta-adrenergic agonist on lymphoproliferation o f PBMCs cultured
for 5 days ............................................................................................................................. 87
ix
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
LIST OF ABBREVIATIONS
ACTH = Adrenocorticotropic hormone/adrenocorticotropin
ADX = Adrenalectomized
ANS = Autonomic nervous system
AP-1 = Activator protein-1
CMF-PBS =  Calcium and magnesium free phosphate buffered saline
CNS = Central nervous system
CREB = cAMP responsive element binding protein
CRFs = Corticotropin releasing factors
CRH = Corticotropin releasing hormone
CTL = Cytotoxic T lymphocytes
E = Epinephrine
DAG = Diacylglycerol
EDTA =Ethylene diaminetetraacetic acid
EIV = Equine influenza virus
G = Gelding
GAB A = Gamma amino butyric acid
y-3-MSH = Gamma-3-melanocyte stimulating hormone
GR = Glucocorticoid receptors
GRE = Glucocorticoid response elements
HA = Hemagglutinin
HAI = Hemagglutination inhibition
HPA = Hypothalamo-pituitary-adrenal
HPLC = High performance liquid chromatography
Ig = Immunoglobulin
IL = Interleukin
IP3 = Inositol triphosphate
IP4 = Inositol tetraphosphate
ISCOM(s) = Immune stimulating complex(s)
LAK = Lymphokine activated killer 
M = Mare
MHC = Major histocompatibility complex
MP = Matrix protein
NA = Neuraminidase
NE = Norepinephrine
NK = Natural killer
NP = Nucleocapsid protein
PBMCs = Peripheral blood mononuclear cells
PIP2 = Phosphatidylinositol 4,5-biphosphate
POMC =Proopiomelanocortin
PWM = Pokeweed mitogen
SE = Standard Error
x
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
SI = Stimulation index 
U = Unit
WHO = World Health Organization
xi
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
ABSTRACT
Stress has been related to increased plasma epinephrine (E), norepinephrine (NE), 
and glucocorticoids. These compounds produce immunomodulatory effects by interacting 
with hormone receptors on or in various immune cells. This project assessed the effects o f 
stress on equine influenza virus (EIV)-specific and mitogen-induced lymphoproliferation 
o f peripheral blood mononuclear cells (PBMCs) in relation to stress-induced changes in E, 
NE, and cortisol. In vitro effects o f amines on proliferative responses and glucocorticoid 
receptor (GR) assays were done as a secondary measure of hormone and neurotransmitter 
interactions with the immune system.
Time-dependent, saturable-specific hormone binding to GRs was abolished by heat 
treatment and subcellular localization o f GR fluctuated in a diurnal manner. Nuclear GR 
was lowest (P<0.05) at 2AM and total binding was highest (P<0.05) at 2PM. In 
experiment two, horses were subjected to five different stress tests including sham/stalled 
(SS), sham/psychological (SP), minimal exercise stress (MES), slow gallop/moderate 
exercise stress (SG), and fast gallop/intense exercise stress (FG). Circulating 
concentrations o f E increased in SG and FG. Influenza-specific blastogenesis increased 
(P<0.05) during the sham/stalled stress test. Mitogen-induced lymphoproliferative 
responses were lower (P<0.05) for samples collected during MES. There was no 
correlation between stress-induced hormone concentrations and lymphoproliferative 
responses.
xii
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Norepinephrine stimulated (P<0.05) mitogen-induced lymphoproliferation in vitro. 
ElV-specific lymphoproliferation was not affected by E or NE. Isoproterenol stimulated 
mitogen-induced lymphoproliferation. Thus, P-adrenergic receptors may be related to 
stimulatory effects o f NE.
Ponies were subjected to SS, MES, SG, and FG. Circulating cortisol 
concentrations decreased (P<0.05) during SG and FG. Lymphoproliferation did not 
change relative to stress. Prior history o f the ponies and measurable cortisol 
concentrations suggested that long-term effects o f rearing processes are important to the 
stress response in adult animals.
Results from this study suggest that stress-dependent changes in E, NE, and 
glucocorticoid concentrations are unlikely to be primary mediators for stress-induced 
changes in lymphoproliferative responses. Other putative factors or a combination of 
hormones and amines may be involved in stress-induced modulation of 
lymphoproliferation.
xiii
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CHAPTER I: INTRODUCTION
The equine industry is largely dependent on pleasure, performance, and race horses 
that are all subjected to varying degrees o f physical exertion. Typically, horses are 
shipped to locations where they are exposed to a large and/or a new population of 
animals. Horses stressed by intensive exercise regimes associated with racing and 
performance activities and horses subjected to transportation stressors are susceptible to 
common and serious infections including influenza (1). Outbreaks of influenza may have a 
serious impact on the equine industry since epidemics o f influenza virus infections have 
caused large economic losses as well as loss o f life (1). Available vaccines do not provide 
adequate protection against influenza virus infection (2). This research project was 
performed to improve our understanding o f the relationship between stress and the impact 
that stress may have on the incidence and severity o f disease.
Stress has been broadly defined as response o f the body to any stimulus that 
disturbs its normal physiological equilibrium or homeostasis (3). The classical response to 
stress involves activation o f the hypothalamic-pituitary-adrenal (HP A) axis and associated 
release o f glucocorticoids and catecholamines (4). Stress-induced effects on the immune 
system may be mediated by hormones o f the HPA axis, autonomic outflow, or a wide 
range o f humoral compounds that may be released in response to a specific stressor. The 
combination and amount o f humoral compound that may be released depends on the type, 
intensity, and duration o f a stressor as well as the history o f the subject, the subjects 
perception of a stressor, and whether environmental/sociocultural factors contribute to 
recovery from stress (5).
1
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I proposed that I would initially study the relationship between stress-dependent 
secretion o f glucocorticoids and catecholamines and selected immunological parameters. 
The rationale for this was that all stressors are associated with the release o f 
glucocorticoids and catecholamines. Further, both of these compounds could easily 
contribute to changes in resistance to disease since they effect a wide variety of 
immunological functions in numerous species (6 - 9). The effects that these compounds 
may have on equine immune function have not been clearly defined.
In the first set o f experiments, endpoints were established in order to demonstrate 
glucocorticoid receptors (GR) in equine PBMCs and determine if there were diurnal 
fluctuations in total, cytosolic, or nuclear GR. This experiment would also help to identify 
time points when nuclear GR was available to produce effects on transcription or interfere 
with the effectiveness o f catecholaminergic stimuli. The second set o f experiments was 
done to characterize norepinephrine (NE) and epinephrine (E) in the circulation o f horses 
at rest and horses subjected to different stressors in order to get a better idea o f release 
that may be typical for the equine species. Effects o f these same stressors on mitogen- and 
equine influenza virus (ElV)-induced lymphoproliferation were also tested. Finally, I 
tested for a correlation between catecholamine concentrations and lymphoproliferation. 
The third set o f experiments was designed to test in vitro catecholamine effects on 
mitogen- and EIV- induced lymphoproliferation and to obtain preliminary data on the type 
of receptor class that might be involved in E and/or NE effects. Finally, the fourth set of 
experiments characterized cortisol concentrations in resting and stressed ponies. These
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
experiments measured mitogen-induced and ElV-specific proliferation and tested for a 
correlation between cortisol concentrations and lymphoproliferation.
The information gained from this work may provide data for future 
pharmacological studies which evaluate whether specific neuroendocrine compounds may 
be used to enhance the effectiveness o f existing influenza vaccines. This data may also 
help to elucidate therapeutic measures to improve the management o f equine 
immunological functions when animals are subjected to psychological, infectious, or 
physical stressors.
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CHAPTER II: LITERATURE REVIEW
A. Anatomical Relays Involved in the Stress Response
Pathways important to coordinating function o f the nervous, endocrine, and 
immune systems include clearly discemable anatomical connections and less clearly 
defined humoral interactions which were originally attributed to hormone functions (6,
10). This research project was designed to study activity o f the hypothalamo-pituitary- 
adrenal (HPA) axis and autonomic nervous system (ANS) in relationship to basal and 
stress-induced changes in the proliferative response o f peripheral blood mononuclear cells 
(PBMCs).
I. Hypothalamo-Pituitary-Adrenal Axis
The HPA axis plays a central role in mediating the effects o f stress on immune 
function (4, 10, 11). Stimuli activating the hypothalamus cause the release of 
corticotropin-releasing-factors (CRFs) which stimulate pituitary corticotropes to secrete 
pro-opiomelanocortin (POMC) peptides including adrenocorticotropin (ACTH).
Secretion o f ACTH stimulates cortisol release from the adrenal cortex (12, 13).
Adrenocorticotropin is the primary regulator o f cortisol synthesis and release. 
However, elevated plasma corticosteroid concentrations have been measured when there 
is not a coincident increase in plasma ACTH concentrations (14, 15). Three possible 
mechanisms for ACTH-independent corticosteroid release have been described including 
direct autonomic innervation of the adrenal cortex by cholinergic nerves, indirect 
activation o f the adrenal cortex by paracrine secretions such as epinephrine or co-localized 
interleukin (IL)-l, and the release o f other hormones that regulate sensitivity o f the
4
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adrenal cortex to ACTH (16). Putative factors that may be involved in the latter activity 
include y -3-melanocyte stimulating hormone (y-3-MSH), growth hormone, 
prostaglandins, interferons, and other peptides (16).
Gamma-3-melanocyte stimulating hormone is a cleavage product o f  POMC (16). 
Gamma-3-melanocyte stimulating hormone enhances ACTH-dependent release o f 
corticosterone in vitro and in vivo (16). In general, y-3-MSH is secreted with ACTH but 
it probably does not play a role in the absence o f ACTH (16).
Growth hormone potentiates the effects o f ACTH in hypophysectomized rats but it 
has no independent effect on cortisol secretion (17). Prostaglandins can also increase 
steroidogenesis in the adrenal gland (15) but the physiological significance o f 
prostaglandin effects on glucocorticoid synthesis has not been elucidated. In addition to 
the aforementioned substances, factors derived from the thyroid gland, the liver, and the 
thymus may potentiate ACTH effects on steroidogenesis in isolated or in in vitro 
preparations o f the adrenal cortex (15). Other humoral factors that may effect sensitivity 
o f the adrenal gland to ACTH include lymphokines derived from lymphocytes or from 
chromaffin cells o f the adrenal medulla (14, 15).
A number o f factors regulate hormone release from pituitary corticotropes. 
Corticotropin-releasing factors bind to pituitary corticotropes to stimulate synthesis of 
POMC and release o f ACTH and other adenohypophyseal products o f POMC (11). 
Vasopressin acts through V, receptors to amplify corticotropin releasing hormone (CRH) 
effects on ACTH secretion (11). Oxytocin has also been shown to enhance the effect of 
CRH on ACTH secretion (11).
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Catecholamines stimulated murine pituitaries to secrete ACTH by acting on alpha- 
1- and beta-adrcncrgic receptors (4). Angiotensin-II has also been shown to increase 
secretion o f ACTH in various animal models (11). Other factors including vasoactive 
intestinal polypeptide, serotonin, and atrial natriuretic factor control POMC synthesis, 
processing, and/or release o f its hormone products in horses (18, 19).
Central regulation o f the HPA axis has been related to brain structures which 
include the amygdala, hippocampus, septal area, cingulum, orbital cortex, and brainstem 
regions (20, 13). The HPA axis is also influenced by changes in blood volume, body 
temperature, and pain (20). These stimuli act through neural pathways typically involving 
adrenergic innervation o f the hypothalamus by cell groups with perikarya localized in the 
brainstem (21). Catecholamines have divergent effects on central control o f the HPA axis. 
In rats, catecholamines have a stimulatory effect on the HPA axis by acting on alpha- 
adrenergic receptors and an inhibitory effect mediated by beta-adrenergic receptor 
activation (20). Neurotransmitters like gama-aminobutyric acid (GABA), morphine, and 
opiates also have an inhibitory effect on activity o f the HPA axis (20).
Glucocorticoids play an important role in controlling the secretion o f hormones 
from the hypothalamus, pituitary, and the adrenal medulla (Figure 1). They have a 
negative feedback effect on the pituitary, hypothalamus, and extra-hypothalamic areas 
(22). Chronic stress and glucocorticoids down-regulate glucocorticoid receptors (GR) in 
extra hypothalamic areas o f rats, reduce responsiveness o f the hippocampus to negative 
feedback, and gradually destroy neurons in the hippocampus (Figure I).
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Figure 1: Hypothalamo-pituitary-adrenal axis and feedback control. This figure 
summarizes relationships important to glucocorticoid feedback on the hypothalamo- 
pituitary-adrenal axis. The figure also summarizes glucocorticoid effects on other body 
systems and the hippocampus as well as glucocorticoid effects on the secretion of the 
other hormones (adapted from McEwen (23) with permission).
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2. Autonomic Nervous System Innervation o f Lymphoid Tissue
Innervation o f  lymphoid tissues by the ANS has been well characterized in 
vertebrates (Figure 2). Lymphoid organs and tissues including the tonsils, jugular body, 
thymus, thoracic duct, lymph nodes, spleen, Peyers patches, cistema chyli, appendix, bone 
marrow, and bursa fabricius are innervated (24). Recent research has demonstrated that 
this innervation can effect immune responses when neurotransmitters bind to specific 
receptors on lymphocytes and other immune tissues or neurotransmitters may regulate the 
immune cell environment (25, 26).
Bone marrow is innervated by nerves that enter through the nutrient foramen of 
the bone (27). Myelinated and unmyelinated nerves divide repeatedly into several nerve 
bundles that run along the course o f the nutrient artery. There is substantial innervation of 
hematopoietic sites such as the sinusoidal parts and parenchymal elements (27).
Myelinated nerves are found alone or within bundles o f unmyelinated nerves and they are 
less numerous then unmyelinated fibers in newborn rats.
The thymus is a primary organ of the immune system. It is a specialized gland 
capable of supporting maturation of T lymphocytes (28) and in mice it regulates 
development and integrity o f  the HPA axis (6, 29). Vagal nerve fibers o f the ANS 
innervate the thymus early in development (30). The vagus nerve develops complex 
corticomedullary boundary nerve nets as the thymus completes development. Vagal fibers 
aid in structural maturation o f the thymus and innervation is followed by migration of T 
lymphocyte precursor populations into the gland (30) During the perinatal and 
prepubescent periods other ANS nerves penetrate parenchyma o f the thymus (29). The
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Figure 2: ANS innervation of lymphoid tissue. This figure illustrates autonomic 
nervous system innervation of different lymphoid organs and tissues based on research 
results from mice and chickens. Lymphoid organs and tissues include tonsils, the jugular 
body, thymus, thoracic duct, lymph nodes, spleen, Peyer*s patches, cisterna chyli, 
appendix, bone marrow, and bursa fabricius. (adapted from Bulloch (24) with permission).
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thymus in adult mice is supplied by the vagus, phrenic, and the recurrent laryngeal nerves 
as well as the superior cervical and stellate ganglia o f the cervical and thoracic sympathetic 
chain (3 1). Innervation o f the thymus gland is similar in various species (32). Nerves 
innervating the thymus o f rats and mice have their cell bodies in the nucleus ambiguous 
and the nucleus reteofaciola (30, 32). Cell bodies are also localized in three distinct 
columns in the cervical spinal cord (C1-C4) and in the nodose and superior cervical 
ganglia (32, 33). Studies on innervation o f the thymus in chicks have reported similar 
localization o f cells which project to the thymus (33).
The thymus contains the primary parasympathetic neurotransmitter acetylcholine 
and the sympathetic neurotransmitter norepinephrine. It also contains other ANS-related 
neurosubstances and hormones such as Substance P, vasoactive intestinal peptide, 
somatostatin, neurotensin, GABA, and calcitonin (24).
The bursa o f Fabricius, a small, oval, hollow organ which lies at the end of the 
cloaca in birds, is the site o f  B cell genesis (34). A layer o f tissue lining the lumen of the 
bursa contains lymphoid tissue. The bursa is supplied by nerves derived from the pelvic 
plexus which include both sympathetic and parasympathetic fibers (35). Although some of 
the nerve fibers enter the nodules, most o f the lymphoid tissue is superficially innervated 
(35). The adult bursa also contains micro-ganglia which are derived from a single 
ganglion during embryogenesis (36).
The spleen is a secondary lymphoid organ capable of protecting the body against 
blood-borne pathogens (37). Normally T and B lymphocytes are transported via the 
splenic artery as they enter the spleen and they are spread within specific zones o f the
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white pulp (37). The spleen is primarily innervated by the celiac ganglion (24). The celiac 
ganglion receives input from CNS nerves that originate in the medial column of the 
thoracic spinal cord (T5-T9) and traverse the upper and lower splanchnic nerves (24).
The majority o f splenic nerves project directly to the parenchyma along the trabecular 
arteries to enter the arteriole trees o f the white pulp (38). Occasionally, nonvascular- 
associated fibers stretch into the white pulp and are located in close proximity with 
lymphocytes (38). In mice and in cats, catecholaminergic innervation terminates at the 
junction between the splenic white and red pulp (39). In other strains o f mice, 
catecholaminergic innervation to the red pulp is limited (38). In addition, the vagus nerve 
effects the spleen indirectly by innervating the splenic artery (37). The spleen also 
contains catecholamines derived from the circulation (39).
The lymphatic system transports lymph and lymphatic cells in the body through a 
number o f  interconnecting vessels. Sympathetic and parasympathetic fibers innervate fully 
developed lymphatic tissues (40). The thoracic duct, which is a major lymphatic duct, is 
innervated by the vagus and the intercostal nerves (41). The cistema chyli is supplied by 
the Xlth thoracic ganglion and the left splanchnic nerve (40). Lymphatic ducts in the 
lower body are innervated by the femoral nerve and by lymphomotor nerve fibers that 
parallel the femoral artery in canine (42). In addition, small ganglia and periadventitial 
nerve plexuses surround the thoracic duct and other lymphatic channels (41).
Lymph nodes are highly organized structures o f the immune system which are 
distributed throughout the body (24). Lymph nodes contain both T and B lymphocytes 
(24). Each region of the body contains defined afferent lymphatics which are drained by a
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node or set o f nodes (40). Innervation of lymph nodes by ANS fibers is different from that 
found in thymus and spleen as it is not as dense or as regionally organized (30).
However, acetylcholinesterase-positive fibers are confined to the capsule and 
subcapsullary zones whereas catecholaminergic fibers form perivascular plexuses inside 
lymph nodes (30, 43). It is rare to find fibers in the deeper layers o f the germinal center in 
lymph nodes o f mice and only a few nerve fibers are typically visible in the parenchyma 
(30, 43). Strain differences have not been detected in innervation o f lymph nodes (30).
Peyer’s patches are assemblies of lymphoid nodules located in the intestinal 
mucosa (40). They consist o f compact lymphatic tissue and have a large lymphopoietic 
reaction center surrounded by a layer of dense reticular fibers (40). Peyer’s patches 
predominantly have specialized functions related to the mucosal immune response (44).
The origin o f nerves that innervate Payer's patches has not been characterized. However, 
reticular cells in mice have been associated with axons and synaptic-like contacts while 
lymphocytes have been found to be related to axon terminals containing synaptic vesicles 
(40).
The appendix or vermiform process is the lymphoid tissue associated with the 
gastrointestinal system (40). Submucosa o f the appendix contains a large amount of 
lymphoid tissue which is segregated into different regions (45). Lymph nodules and T 
cell-dependent lymphoid areas are traversed by large linear branches o f varicose nerve 
fibers that facilitate interactions between neurotrophic factors and local immune responses 
in rabbits (45).
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B. Biological Significance o f Stress
Recent progress has been made in elucidating neurobiological processes involved 
in the stress response. Biological changes that occur during stress include an array of 
responses that have been described as the "flight or fight" defense response (9). Normally 
these biological responses prepare the organism to cope with stress by increasing the 
readiness and reactive behaviors and biological functions that will increase the probability 
o f survival.
Figure 3 shows some o f the social, psychological, and personal characteristics 
which may result in individual differences in activation o f the HPA axis and the ANS as 
well as changes in immune functions and health that may be related to a particular stressor 
(9). Exposure to stress that is perceived as uncontrollable characteristically results in 
impaired immunological functions (46), increased catecholamine release (47), increased 
activity o f the o f HPA axis (48), and a greater incidence of neurodegenerative disorders 
(49). Clinical studies in humans have revealed that stress is associated with the onset of 
depressive and physical illnesses (49, 50). Stressful events that are associated with the 
onset o f depression are usually perceived as uncontrollable and therefore present a feeling 
o f powerlessness. A few examples of such events are death o f a close relative and serious 
illness (51). Prevention and treatment of stress-related disorders can be improved by 
elucidating biological factors that mediate these changes and by identifying immune cell 
types and immunological functions that are adversely effected by specific compounds.
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Figure 3: Factors which modify the effects of a stressor on activation of the HPA axis and the ANS. This figure 
summarizes biological, psychosocial, and psychological factors that have been reported to effect the magnitude of a stress 
response. A number of factors have been reported to abolish responsiveness or alter activation of the HPA and the ANS in 
response to a particular stress. Factors which consistently alter the stress response are indicated in the left part o f the figure. 




Research has demonstrated significant bi-directional communication between the 
nervous, neuroendocrine, and immune systems (6). The interrelationship between immune 
and neuroendocrine circuits is illustrated in Figure 4. The central nervous system (CNS), 
pituitary gland, and the immune system communicate directly and indirectly (10, 52).
Immune functions altered by nervous and neuroendocrine systems include 
ontogeny o f T and B cells, accessory cells, and the development and function of bone 
marrow, thymus, lymphocytes, and spleen of humans (9). The nervous and 
neuroendocrine systems also regulate migratory patterns o f cells from bone marrow to 
thymus and homing of immune cells (30).
Nervous system and neuroendocrine effects on the immune system are mediated by 
neuroactive substances that act as paracrine, neurocrine, or hormonal effectors (10). 
Catecholamines and glucocorticoids are believed to be the primary effectors involved in 
neural and neuroendocrine regulation of immune function (8). The immune system 
secretes a number o f compounds that may feed back on neural and neuroendocrine cells to 
modify immune function (53). In addition, infection and/or various diseases cause the 
release of compounds from the immune system that act to elicit changes in function of 
neural and endocrine systems (9, 54). Cytokines are believed to be the most important 
effectors involved in immunological effects on neural and neuroendocrine systems (53). It 
has also been shown that activated lymphocytes produce ACTH-, y-endorphin-, thyroid- 
stimulating hormone, and human chorionic gonadotropin-like peptides (8, 55). These
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Figure 4: Pathways involved in interactions between the nervous 
and im m une systems. This figure illustrates direct and indirect relationships between 
neuroendocrine secretions and the immune system. ACTH = adrenocorticotropic 
hormone; CSF = colony stimulating factor; EL-2 = interleukin-2; MEF = macrophage 
inhibitory factor; ylF = y interferon, RES = reticuloendothelial system; TSH = thyroid 
stimulating hormone. (Adapted from Hall and Goldstein (56) with permission).
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lymphocyte secretions may act to directly control endocrine function by conventional 
mechanisms or these secretions may act on other cells in the immune system (54, 57).
1. Glucocorticoids and the Immune System
Glucocorticoids are released following activation o f  the HPA axis (12). 
Glucocorticoid effects on the immune system were recorded in the mid-nineteenth century 
when it was noted that there were more white blood cells in an Addison’s disease patient
(58). The importance o f glucocorticoids to immune function was verified in the mid­
forties when it was reported that injection o f ACTH increased antibody titers in humans
(59). It was also demonstrated that stress-induced secretion o f glucocorticoids stimulated 
defense mechanisms and increased resistance to stressful conditions (59). These results 
were not reproducible when improved immunological assays were used (60).
It was in the 1950's that physicians referred to glucocorticoids as the miracle drug 
for allergic syndromes (12). This development followed pre-clinical research that 
demonstrated immunosuppressive and anti-inflammatory actions of glucocorticoids (61). 
The physiological role o f normal glucocorticoid concentrations was not fully appreciated 
at that time (12, 60).
By the time that the role of the HPA axis in regulating the immune system started 
to be established mechanisms involved in regulating lymphoid tissue were fairly well 
characterized. Evidence demonstrating a physiological role for the HPA axis in regulating 
the immune system included observations on hypertrophy o f the thymus in 
adrenalectomized rats (62) and thymus atrophy associated with stress-induced adrenal
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enlargement in rats (63). It had also been shown that purified steroid extract from the 
adrenal cortex could reverse thymic atrophy (63). Furthermore, research in rats and mice 
has shown that increased blood corticosterone levels parallel increases in immune response 
to experimentally injected antigen (6). Subsequent studies demonstrated that 
adrenalectomy abrogated the aforementioned effects (64).
Many o f the immunosuppressive actions o f glucocorticoids are observed at steroid 
concentrations that are equivalent to therapeutic and/or stress-induced levels (65). 
Glucocorticoid therapy that is commonly utilized in clinical situations has a wide variety of 
effects on the immune system. The suppressive effects seen following acute treatment 
with glucocortiocids continue as long term effects in humans (10). Acute effects o f 
glucocorticoids have been related to leukocytosis, neutrophilia, decreased pan T cells, and 
monocytosis (10). Glucocorticoids inhibit almost all functions o f monocytes and 
macrophages including chemotaxis, antigen presentation, and cytokine release in humans 
(66). Glucocorticoid effects on mononuclear phagocytes are indirectly mediated due to 
the inhibition o f cytokines required to activate phagocytic function (67). Glucocorticoids 
may also stimulate immunoglobulin production in humans (68). Decreased production of 
interleukin (IL) -1 and increased production o f IL-6 have also been related to 
glucocorticoid release (10). Further, intravenous glucocorticoid treatment has been 
reported to enhance NK cytotoxicity after 4 hours (69). Glucocorticoids and ACTH 
decrease allergic, rheumatic, and collagen diseases (61).
Anti-inflammatory and immunosuppressive effects o f glucocorticoids play a role in 
physiological mechanisms important to coping with various stressors (70, 65). These
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actions are induced through glucocorticoid receptor-mediated processes (71). 
Glucocorticoids act on cells by binding to specific intracellular receptors and many types 
o f immune cells, in various species, have glucocorticoid receptors including murine 
lymphoma hybrids (72) and PBMCs (73).
There are two types of glucocorticoid receptors in mammalian species (74). The 
type I receptor has a high affinity (KD = 0.5 nM) and low capacity for glucocorticoids and 
it is analogous to the classical mineralocorticoid receptor localized in the kidney, salivary 
glands, and colon (74). The type II receptor, is similar to the classical glucocorticoid 
receptor (GR) localized in the liver (74). This receptor has an lower affinity and higher 
capacity for glucocorticoids.
Hormone binding to the GR activates the receptor and increases its affinity for 
chromatin (Figure 5). Hormone-bound GR binds to glucocorticoid response elements 
(GREs) which regulate transcription of various genes (75). Glucocorticoid effects may 
also involve binding to GREs that overlap binding sites for the cAMP response element 
binding protein (CREB) (6). This interaction may block or reduce the effectiveness o f 
stimuli acting through cAMP cascades. Further, hormone occupied GR may bind to sub­
units o f AP-I protein and prevent the action o f AP-1 nuclear protein dimers on 
transcription (76, 77). This then modifies early activation o f cells effected by protein 
kinase C-dependent stimuli. Thus, glucocorticoid effects on cells may involve direct 
genomic effects on transcription, genomic effects that alter cAMP-dependent 
transcription, or genome-independent protein interactions that alter effectiveness of A P-1 
dependent stimuli.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.









Figure 5: Receptor mediated genomic actions of glucocorticoids. This figure 
summarizes receptor-mediated mechanisms for glucocorticoid effects at the gene level.
H.= free hormone; HR = hormone-bound receptor, HSP90 = heat shock protein 90; HR1 
activated hormone receptor complex; HR’n=activated hormone receptor complex 
translocated into the nucleus. (Adapted from Munck and Guyre (65) with permission).
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2. Catecholamines and the Immune System
Catecholamine release caused by physical or psychological stress depends on 
activation o f the CNS and the related response of the ANS (78). Acute systemic release 
o f  catecholamines during exercise stress has been related to reduced lymphoproliferation 
in murine species (79). Further, denervation and/or pharmacological treatments that 
prevent neurotransmitter release in or from the adrenal medulla, thymus, or lymph nodes 
may alter specific immunological functions such as in vivo proliferation of immune cells in 
lymph nodes, spleen, and bone marrow (21, 80). For example, in mice, chemical 
sympathectomy diminished the primary antibody response by as much as 80% and 97% in 
spleen and lymph nodes, respectively. Denervation and/or pharmacological blocks of 
sympathetic transmitter release also reportedly reduced the secondary antibody response 
and resulted in a 50% reduction in T cell-mediated responses including delayed 
hypersensitivity to epicutaneous immunization and cytotoxic T-lymphocyte response to 
alloantigens (21, 37, 80). The same experimental reports described enhanced 
Iipopolysaccharide-stimulated proliferation and enhanced immunoglobulin production by 
lymph node cells following denervation or pharmacological block of sympathetic activity. 
These findings may be o f considerable importance to veterinary medicine since production 
o f  neutralizing antibodies is dependent on T cell help and such antibodies are necessary for 
protection against equine influenza infection (81).
Catecholamines regulate lymphocyte trafficking, vascular permeability, and blood 
flow in lymphoid organs (21). Chemical sympathectomy increased the prevalence of 0- 
adrenergic receptors on murine lymphocytes and caused complete loss o f NE in rat spleen
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
22
and other innervated organs (37). Sympathectomy altered the distribution o f murine 
lymphocytes in the spleen and abolished efflux o f  leukocytes from spleen (21). 
Sympathectomy in 8-week-old mice caused a reduction in the percentage o f T and B cells 
in the spleen (21). Neonatal sympathectomy also caused an alteration in the relative 
percentage o f T-cell subsets within the spleen due to decreased numbers o f CD8* cells in 
sympathectomized mice (37). Although the percentage o f T cells was not changed 
following sympathectomy, the proportion o f CD8+ cells was 50% of that counted in 
control mice.
The severity and incidence o f autoimmune diseases may be increased by 
sympathectomy (82). Antibody-mediated, but not T-cell-dependent and T-cell-mediated, 
autoimmune diseases were significantly augmented after sympathectomy (82). 
Sympathectomy also affects NK cells. Sympathectomized 2-week-old CBA mice initially 
had relatively low levels o f  NK activity, which increased at 4 weeks, and subsequently 
declined to low-Ievels by 6 weeks (82). The transient increase in NK function after 
sympathectomy was attributed to loss o f the restraining influence o f catecholamines on 
NK activity or to effects o f  the sympathetic nervous system on migration patterns or 
maturation o f splenic NK cells (82).
In vivo experiments have demonstrated that blood mononuclear cell subsets as well 
as NK cell and lymphocyte functions were altered during stress and 2 hours after exercise 
stress (83). These effects were mimicked by exogenous administration o f epinephrine 
(83). Epinephrine induced smaller increases in leukocyte concentrations compared to the 
cell concentrations measured in stressed humans (83).
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Catecholamines alter immunological functions by binding to multiple classes o f P 
and cc-adrenergic receptors. Studies performed in a number of species (human, rat, 
mouse, guinea pigs, rabbit) suggest that the most dramatic and wide-spread effects of 
catecholamines are dependent on P-adrenergic receptors (reviewed in 84). Beta- 
adrenergic agonists inhibited T cell proliferation in response to lectins or IL-2, reduced 
lectin-stimulated proliferation o f B cells, and inhibited the generation o f lymphokine 
activated killer (LAK) cells in humans (85). The non-specific P-agonist isoproterenol also 
reduced IL-2 production by human lymphocytes and down regulated EL-2 receptors on 
lymphocytes and T-cell lines (86). Mice treated with cAMP analogues, or P-adrenergic 
agonists which act through cAMP cascades, had reduced cytotoxicity mediated by 
antigen-specific cytolytic T lymphocytes, NK cells, and other non-specific killer cells 
including macrophages and monocytes (87, 88). In addition, antibody secretion in mice 
was inhibited by p-adrenergic agonists (89). Results from experiments using specific 
and/or non-specific P-adrenergic antagonists have generally supported the conclusion that 
catecholamine binding to P-adrenergic receptors inhibits murine immune functions (90).
Cyclic AMP, which acts as a second messenger mediating adrenergic effects, has a 
role in promoting differentiation o f immature lymphocytes probably by initiating the S 
phase o f mitotic division and DNA synthesis following mitogen stimulation (91). Elevated 
cAMP levels in humans have been associated with the inhibition of mature differentiated 
lymphocyte functions (91). Cyclic AMP inhibited lymphoproliferation in murine species 
and this effect was dependent upon inhibition o f C a"  influx (92).
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Possible mechanisms for cross-talk between the trans-membrane signaling events 
elicited by stimulation o f (3-adrcncrgic receptors and T-cell receptors are summarized in 
Figure 6 (92). Stimulation o f  T-cell receptors caused hydrolysis o f phosphatidylinositol 
4,5-biphosphate (PEPz) due to activation o f phospholipase C and this yields inositol 
triphosphate (IP3) and diacylglycerol (DAG). Further, EP3 can be converted into inositol 
tetra phosphate (EP4) and water soluble EP3 can release intracellular sources o f C a"  ions 
whereas IP4 may regulate plasma membrane Ca*" ion channels in mice (92). Protein 
kinase C and increased Ca"* may inhibit increases in cAMP that are induced by beta- 
adrenergic stimulation (84).
Alpha-adrenergic receptor stimulation by catecholamines enhanced proliferation 
o f CD3*, CD4*, and CD8* lymphocytes in humans (84, 93). These catecholaminergic 
effects were more pronounced for CD8* than for CD4* cells (84, 93).
The existence o f adrenergic receptors on lymphocytes, monocytes, and neutrophils 
was demonstrated in the early 1980s (94 - 96). Typically P- adrenergic receptors are 
found on murine and human B and T lymphocytes (84, 93). Receptor density varies 
among subsets o f T cells, with the number o f receptors on human T suppressor/cytotoxic 
cells being greater than that on T helper cells (93). Further, CD8" cells have many more 
P-adrenergic receptors than CD4+ cells and the number o f  P-adrenergic receptors per cell 
has been correlated with prolife .tive response of these cells (93). There is limited 
information on immune cells with cc-adrenergic receptors and whether immune cells and 
tissues in the equine species have adrenergic receptors has not been investigated.













Figure 6: Proposed mechanisms for P-adrenergic effects on T cell activation. The 
possible mechanisms for cross-talk between transmembrane signaling events elicited by 
stimulation o f P-adrenergic and T-cell receptors are summarized in this schematic. AC = 
adenylate cyclase; BAR = beta adrenergic receptor; Ca = calcium ions; cAMP = cyclic 
AMP; DAG = diacyl glycerol; ER = endoplasmic reticulum; G = G protein; Gs = 
stimulatory G protein; IP = phosphoinositol; PEP2= phosphatidylinositol 4,5-biphosphate; 
PKA = protein kinase A; PKC = protein kinase C; PLC = phospholipase C; TCR = T-cell 
receptor; (Adapted from Roszman and Carlson (92) with permission).
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D. Infection and Disease Potential o f  Stress
The pioneering work o f Dr. Seiye demonstrated that restraint and injury frequently 
result in disease (97). Subsequent studies have demonstrated that various stressors 
including, physical, chemical, and psychosocial stress may have drastic effects on immune 
function and the related susceptibility to disease. Prolonged aggravated stress, psychotic 
states, and disorders o f the ANS or the endocrine systems disrupt cortical control o f 
neuroendocrine regulation and have detrimental effects on immune function (98, 99).
Stress associated with unpleasant and grieving personal experiences has been 
correlated with the sudden onset o f disease (100). Humans that suffer from chronic 
distress, irritation, and frustration ultimately became discouraged, chronically depressed, 
and they contract a variety o f diseases (5, 101). Obese humans on high fat diets but with a 
lifestyle including social cohesion, close personal relationships, and little sociocultural 
change, had a lower incidence o f coronary atherosclerosis, sudden death, and/or 
myocardial infarction as compared to matched subjects that suffered from chronic stress 
(102, 103). Bereaved persons not only change their lifestyle but also are at risk for a wide 
variety o f  diseases or the exacerbation o f existing diseases (100). Plasma corticosteroid 
levels were elevated in some bereaved persons (100). Older subjects o f both sexes who 
were facing bereavement, or who had been widowed, had higher urinary levels of 
norepinephrine or epinephrine when they were anxious or depressed as compared to 
matched subjects who were not coping with death o f a closely associated individual (104). 
In high risk populations, the probability that stress will induce disease is 0.14 (105).
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The incidence o f coronary artery disease (CAD) is normally very low in stable 
communities and societies (106). However, coronary atherosclerosis develops early in the 
life o f young men and evolves over many years and stressors during this period may 
interact to increase the development or severity o f CAD (107). Blue collar workers who 
do heavy manual labor or shift work and/or chronic work overload are generally exposed 
to excessive noise and these conditions have been related to a higher incidence of 
myocardial ischemia (108). Brief separation of young animals from their mother 
reportedly results in high blood pressure, persistent elevations o f basal heart rates, 
disturbances in growth, sleep, and body temperature regulation, persistent 
immunosuppression, and a predisposition to opportunistic infection (109).
Mental depression has been associated with a greater number of eruptions in 
individuals with chronic recurrent herpes simplex infections (110). In addition, depression 
was associated with decreased CD8+ cells and this reduction preceded herpes activation 
(111). It was also demonstrated that anxiety and fear preceded the recurrence o f herpes 
simplex infections (111).
Physically and psychologically stressed subjects have an increased incidence o f 
human immunodeficiency virus (HTV) seropositivity (112). Human immunodeficiency 
virus-seropositive individuals living alone had a greater reduction in immune functions as 
compared to immunological endpoints measured in matched HIV-positive controls living 
with a close partner (113). Solitary HIV-seropositive humans experienced a more rapid 
rate o f HIV progression based on lower levels o f CD4* T cells and a lower proliferative 
response to phytohaemagglutinin (113). The same laboratory reported that prolonged
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periods o f depression in HIV-seropositive men resulted in a more rapid decline in CD4* T 
cells when compared HIV-positive matched controls that were not depressed (i i4). In 
HIV-positive subjects studied for an 8-week period, there was no effect of stress on NK 
cell activity or the Iymphoproliferative response to ConA, Candida albucans, or 
Cytomegalo virus antigens. Immunoglobulin A and lymphocyte subsets did not change 
during this study (115).
Immune functions in cancer patients have been studied in relation to psychological 
stress factors. Psychosocial group interactions over a 6-week period enhanced survival of 
malignant melanoma patients and was also associated with an increase in interferon- 
augmented NK activity and the number o f NK cells over a 6-month time period (116). 
Behavioral characteristics o f patients participating in group therapy included lower levels 
o f anxiety and depression and increased levels o f anger at a 6-month follow-up point 
(1 16). Further, breast cancer patients with better coping skills had higher levels of NK cell 
activity than patients who were not as well adjusted (117). Social support and fatigue of 
cancer patients also seems to play an important role in lowering NK cell activity when 
measured over a 3-month period (117, 118). Animal models exposed to stress have an 
increase in the morbidity and mortality o f immune-related disorders and cancer (119).
Although the preceding literature relates primarily to human subjects, studies with 
animal models suggest that similar factors may affect the stress response. Based on 
existing literature (2, 13, 18, 120 - 135) and results from experiments summarized in this
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dissertation this also applies to the equine species. The importance o f these observations 
will be discussed in more detail following presentation of the experimental data.
E. Influenza Infection
Influenza is a pandemic viral respiratory disease which results in high morbidity 
and significant mortality in humans and domestic animals (136, 137). The costs of 
influenza in terms of economic losses can be high; costs per horse during an influenza 
outbreak in a thoroughbred stable in 1975 were estimated to be $700 (136).
Influenza viruses have been divided into 3 types (A, B, C) based on antigenic 
character of their nucleoprotein and the chronological order o f isolation (138). For each 
type, sub-type and strain taxonomy has been based on the antigenicity o f viral 
hemagglutinin (HA) and neuraminidase (NA) antigens (138). In 1980, the World Health 
Organization (WHO) recognized the classification o f fourteen antigenically distinct HA 
groups and nine antigenically distinct NA groups in human, swine, equine, and avian 
influenza A viruses (81). Influenza B and C viruses have no subtypes (138).
I. Biology of Influenza Virus
Influenza is an orthomyxovirus consisting o f an outer lipoprotein envelope and an 
internal helical ribonucleoprotein core termed the nucleocapsid which contains the 
negative stranded viral RNA genome (55). The influenza A virus was the first 
characterized virus o f the orthomyxovirus family (55). It contains ten genes divided 
among eight RNA segments (55). The viral envelope is studded with two types o f surface 
glycoproteins which include HA and NA (137). There are approximately 500 HA 
molecules and 100 NA molecules per virus particle (137). Within the viral envelope is a
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shell comprised o f a matrix protein (MP) which encloses the RNA and associated 
nucleocapsid protein (NP) as well as the proteins which are responsible for RNA 
replication and transcription (137). Hybridization studies suggest that the NP can be 
divided into five groups. This grouping is related to different host origins, which suggests 
that NP may be involved in determining host specificity (137).
Hemagglutinin is responsible for the attachment of virus to cells and for cell 
penetration and it may also mediate cell fusion (137). Hemagglutinin and NA proteins are 
expressed on the surfaces o f influenza-infected cells (55). The FLA protein undergoes 
periodic antigenic changes which are most commonly due to antigenic drift that results 
from the accumulation o f a series o f point mutations or less often to antigenic shift which 
results from genetic reassortment between influenza A viruses from humans and animals 
(137).
2. Immune Response to Influenza Virus Infection
a. Humoral immunity. Antibodies to HA neutralize viral infectivity and 
resistance to influenza infection correlates with anti-HA antibody levels in humans (139). 
Antibodies to NA are less effective than anti-HA antibodies in mediating protection 
against influenza infections (81). Antibody specific for viral NA reduced the severity of 
lung lesions and lowered viral titers in mice (140) and prevented systemic spread o f virus 
and death in chickens (140) but NA-specific antibodies did not prevent infection in either 
o f these species. Antibodies against NA may exert their effect by reducing virus yield and 
cell-to-cell spread o f virus (141). It has been suggested that anti-MP antibodies may also
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contribute to anti-influenza protection, possibly by mediating antibody-dependent cellular 
cytotoxicity o f infected cells (142).
Studies have demonstrated that serum antibody is sufficient to prevent infection of 
the lung (143). For example, experiments with ferrets indicated that immunization of an 
isolated tracheal pouch with influenza virus led to serum antibody and protection o f the 
lung but not the nasal passages (144). The passive transfer o f serum anti-influenza 
antibody to mice (145, 146) and ferrets (144) demonstrated that high titers o f serum 
antibody fail to protect the upper respiratory tract against viral challenge while it protected 
the lungs and prevented development o f  pneumonia. In mice and adult ferrets, protection 
o f the upper respiratory tract from intranasal viral challenges was not provided by serum 
antibody (81). Immunoglobulin A-producing plasma cells produced antibodies specific for 
orally administered antigens in rats (147). Specific antibodies were detected in the gut and 
also in extra-intestinal lymphoid organs such as mesenteric lymph nodes and spleen of 
immunized animals (147).
Intranasal administration of a recombinant vaccinia virus, containing the HA gene 
o f H1N1 influenza induced local protection against H1N1 influenza virus in mice (148). 
Protection was correlated with an increased IgA titer in nasal washes (148). Virus- 
specific IgA was detected in nasal washes o f influenza-infected convalescent humans 
(149). Further, it was reported that the predominant immunoglobulin in nasal washes of 
patients subjected to a secondary intranasal challenge with a H3N2 influenza virus was a 
dimeric IgA which was associated with secretory component (149).
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
32
b. Cellular immunity. Cellular immunity is necessary for recovery from 
influenza infection although cell-mediated immunity probably does not contribute to 
preventing influenza infection (81). Cytotoxic T lymphocytes (CTL) capable of 
recognizing eight o f the ten influenza virus encoded proteins including HA, N A  MP, and 
NP were generated following influenza infection o f mice (55). Cytotoxic lymphocyte 
function plays a major role in the host cellular response to influenza infections (150). A 
minor population o f CTLs from influenza-infected mice was capable o f recognizing HA 
(55) and this cell population may play a role in recovery o f mice from challenge with an 
influenza virus bearing homologous HA (151). Heterotypic immunity in mice is 
presumably mediated by cross-reactive class I major histocompatibility complex (MHC)- 
restricted CD4', C D 8\ a/p  CTLs that recognize influenza virus NP (152). However, 
there was clearance o f influenza virus from respiratory tracts o f mice which lack class I 
MHC-restricted CTLs (153). Bradley and coworkers (154) hypothesized that this 
clearance may be due to class II MHC-restricted CTLs or secretory IgA. Although CTL 
can not per se prevent infection, infection in primed persons may be modified early in its 
course. As CTL recognize the common internal viral proteins also besides glycoproteins 
o f outer membranes o f influenza virions, this protective effect can be broader than that of 
antibody response (150).
3. Equine Influenza
Equine influenza viruses (EIVs) are categorized as type A based on antigenicity of 
their internal proteins (155). Type A EIVs are divided into two sub-types based on 
antigenicity related to the surface proteins HA and NA (155). Influenza viruses are
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codified according to their type, host species, subtype, and place and year o f isolation, 
followed in parentheses by the HA and NA subtypes (156). Equine I influenza is 
designated A/equine 1/Prague 56 (H7N7) and equine 2 influenza virus is referred to as 
A/equine 2/Miami 63 (H3N8) (1). Equine influenza viruses are effected by antigenic drift 
(156). An antigenic variant which gave rise to large seal disease epidemics in the late 
seventies and early eighties involved A/equine 2/Fontainbleau 79 and A/equine 2/Kentucky 
81 (1). More recent virus isolates include A/equine 2/Johannesburg 86, A/equine 2/ 
Ludhiani 87, A/equine 2/Bhiwani 87, A/equine 2/Suffolk 89, A/equine 2/Alaska 91, and 
A/equine 2/Kildare 92 (157).
Equine influenza viruses are very labile and sensitive to disinfectants (1). Equine 
influenza is contracted by inhalation and it is extremely contagious (158). The incubation 
period varies from 1 to 5 days and depends primarily on the dose o f virus challenge (1). 
The short incubation period and persistent coughing which releases large amounts o f virus 
into the atmosphere contribute to rapid spread of the disease (159).
In a susceptible group o f horses, morbidity can be as high as 100% (1). Mortality 
is usually low but can be as high as 10% in foals, donkeys, and in affected horses that are 
not adequately rested (1). The severity o f the disease depends primarily on the general 
immune status o f horses at the time o f exposure, the environment, and the amount of 
stress that the animals are subjected to (129). Equine influenza generally has adverse 
affects on breeding stock and the performance of competition horses without causing 
mortality (129). Show and race horses appear to be particularly susceptible to infection,
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probably due to frequent transport that may cause stress and exposure o f transported 
animals to a large group o f animals (13S).
a. Clinical signs. Both subtypes o f equine influenza viruses produce 
similar clinical signs in horses but equine 2 infections are usually more severe (1). The 
first sign o f infection is an elevation in body temperature up to 41° C which is generally 
biphasic (159). Fever is followed by a dry deep cough which begins a few hours to 2 days 
after the elevation in body temperature. Other clinical signs may include a serous nasal 
discharge which may become mucopurulent due to secondary bacterial infection, myalgia, 
inappetence, and enlarged mandibular lymph nodes (1). Oedema o f the legs and scrotum 
is sometimes observed and spasmodic and impaction colic is also sometimes observed (1).
Horses usually recover clinically from uncomplicated influenza within 10 days but 
coughing may persist for longer than 10 days (1). Secondary bacterial infection(s) 
prolongs the recovery period (1). Pneumonia has been reported in foals, horses that are 
stressed by strenuous exercise, and donkeys which are more susceptible to influenza than 
horses (160).
Equine 2 viruses cause pneumonia more frequently than equine 1 viruses and have 
also been associated with myocarditis (159). Pregnant mares infected with EIV may abort 
or resorb the fetus (1). Chronic pharyngitis, chronic bronchiolitis, alveolar emphysema, 
and sinusitis have been recorded in ElV-infected animals as sequelae.
b. Vaccination. Vaccinated horses are less susceptible to EIV than 
unvaccinated horses or horses that receive fewer vaccinations at an early age. Resistance
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to the disease has been shown to be closely correlated with the vaccination history and HA 
antibody titers at the time of exposure (I).
Wood and coworkers (161) demonstrated that influenza vaccine-induced 
antibodies are short lived, persisting for 4-6 months. Thus, vaccination o f animals against 
influenza virus is not consistently effective largely due to inability to maintain adequate 
antibody titers. The propensity of the virus to undergo drastic antigenic changes 
(antigenic shift and antigenic drift) is one o f the factors which makes production o f a 
consistently effective influenza vaccine difficult (81).
It is advisable to vaccinate young horses at 4-6 month intervals for several years 
after their primary course o f three vaccinations (I). Annual vaccination for race horses 
and competition horses is mandatory in several countries (1). The EIV vaccines that are 
currently available are inactivated. Live attenuated vaccines have proved very difficult to 
develop because o f the inherent mutability o f the virus. Current vaccines in North 
America contain the prototype viruses A/equine 1/Prague 56 and A/equine 2/Miami 63
(162). The majority of vaccines also contain a variant of Miami 63 represented by 
A/equine 2/Fontainbleau 79 or A/equine 2/Kentucky 81 (1). Recently, equine influenza 
vaccines containing immune stimulating complexes (ISCOMs) have become available
(163). In the form of ISCOMs, EIV proteins are highly immunogenic and it is claimed 
that they stimulate a protective immune response which persists for over a year (163).
4. Lymphoproliferative Response to Vaccination and Infection
Lymphocyte blastogenic responses to influenza antigens were detected 3 to 6 days 
after viral infection (164). Helper T-cell activity peaked at day 2, cytotoxic activity was
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detectable by day 4, and cytotoxic activity peaked between days 6 and 8 in mice that 
received intravenous injections o f influenza virus (55). This cellular response leads to 
rapid recovery from subsequent viral challenge (165).
Influenza-specific in vitro lymphoproliferation and IL-2 production by human 
PBMCs were increased following vaccination (166). Saririan and coworkers (167) 
demonstrated that some healthy elderly populations can be separated on the basis of 
responders [hemagglutination inhibition (HAI) titer > or = 40] or non-responders to 
influenza vaccination. Research from the same laboratory further demonstrated that 
lymphocytes isolated from the responders 4 weeks after vaccination had a higher in vitro 
proliferative response than lymphocytes from non-responders (167). Lymphocyte 
proliferation to influenza A virus following live-attenuated virus vaccination o f older 
chronically ill adults increased (168). Age-related decreases in T-cell proliferation have 
been reported in mice inoculated with influenza A virus (169). Factors such as 
prematurity, health status, and previous influenza immunization o f children plays an 
important role in magnitude of T-cell proliferative responses to influenza antigen (170).
Mumford and coworkers (2) demonstrated that in vitro lymphocyte proliferative 
responses in horses were stimulated after they were vaccinated with EIV vaccine. No 
significant CTL activity was induced by any o f the vaccines. However, there was 
significant CTL activity in previously infected ponies that were tested prior to being 
challenged with EIV (H3N8). Four days after challenge infection, CTL activity was 
detected in all vaccinated ponies but the highest response was measured in ponies that had
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been infected previously. Although inactivated influenza vaccines stimulated lymphocyte 
proliferative responses they did not stimulate measurable CTL activity (2).
F. Effects o f Exercise Stress on Humoral and Cellular Immunity
Exercise causes an increase in circulating leukocyte numbers in humans (171). The 
magnitude o f this increase is related to duration and intensity o f exercise and the increase 
may be related to an increase in granulocytes (171). Circulating lymphocytes are also 
increased in humans during exercise and related changes in the relative proportions of T,
B, and NK cells as well as subsets ofT  cells have been reported (171, 172). Total 
leukocytes and granulocytes may remain elevated for several hours after exercise whereas 
lymphocytes may fall below baseline before they return to pre-exercise levels (171, 172).
Pronounced changes in leukocytes and lymphocytes during exercise are usually 
transitory and cell counts are restored to normal levels within 24 hours in humans (173). 
This change may reflect redistribution of cells between different lymphoid compartments 
and not the synthesis of new cells (174). Leukocyte counts in athletes over a long term 
are relatively unaffected by exercise training (171).
Moderate exercise does not appear to change resting total serum immunoglobulin 
(Ig) levels (173). However, resting Ig and specific antibody levels may be decreased by 
intense sport training (173). Resting Ig and specific antibody levels are restored by 
reducing training after the season ends (173). Serum antibodies to specific pathogens may 
be increased following exercise training of mice (175, 176). Secretory IgA was decreased 
after intense prolonged exercise in humans (177). Changes in secretory IgA were 
particularly pronounced in competitive human athletes (177) and IgA levels were partially
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recovered during reduced training periods (178). These transitory changes in IgA may be 
temporally related to the appearance o f upper respiratory tract illnesses including influenza 
infections in elite athletes (179).
There is limited information available on how exercise effects equine immune 
function. Acute maximal exercise results in leukocytosis, lymphocytosis, and a decrease in 
the neutrophil to lymphocyte (N/L) ratio (132, 180). The N/L ratio is increased after 2 to 
3 hours o f exercise due to a drop in lymphocytes and neutrophilia. The acute effects o f 
exercise stress were reduced by training (181). After horses were subjected to intense 
exercise stress on a treadmill, phagocytic activity of alveolar macrophages was depressed 
for up to 3 days (126, 134) and impaired blood neutrophil chemotaxis and oxidative 
metabolism was measured for 1 day after exercise (135).
There are conflicting reports about the effects o f exercise on lymphocyte responses 
to mitogens. Wong and coworkers (135) reported that lymphocyte function was not 
altered by intense exercise in horses. Further, they reported that B-cell activity and serum 
IgM, IgG, and IgA was not affected by exercise. One other study demonstrated a 
suppression of the proliferative response to Concavalin (Con) A and phytohemagglutinin 
(PHA) mitogens following a 30 minute treadmill exercise bout (125). Horohov and 
coworkers (123, 131) reported exercise-induced changes in equine influenza specific 
lymphoproliferation and lymphokine activated killer (LAK) cell activity. Acute exercise 
challenge o f unconditioned horses decreased PWM and EIV type 2-induced 
lymphoproliferation during and after exercise (123). Training o f the horses modified the 
effects of acute exercise stress on immunological functions and the effects of various
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hormones and amines on lymphoproliferation (123). Equine LAK cell activity was 
increased during exercise (123). This increase in LAK ceil activity has been attributed to 
increased responsiveness o f  cells to interleukin-2 (IL-2) rather than to an increase in IL-2 
receptor number or an increase in the number of LAK cell precursors (122).
G. Closing Remarks
Horses that are stressed are more susceptible to disease. All stressors are related 
to release o f glucocorticoid and catecholamines. However, very little is actually known 
about the relationship between stress-induced changes in cortisol and catecholamines and 
the effect that these compounds have on equine immune function. Experiments 
summarized in this dissertation were done to begin to address this deficiency.
The experiment described in Chapter four was done to determine whether equine 
PBMCs have detectable GR. This experiment also characterized diurnal changes in 
subcellular localization o f GR in order to begin to identify time points when nuclear GR 
may be present to interact with GREs or interfere with other second messenger systems.
The experiment described in Chapter five was done to characterize the effect of 
various stressors on catecholamine concentrations in the circulation. Lymphoproliferation 
induced by mitogens and EIV was tested for samples collected during the same stress 
tests. This was done to determine whether acute changes in circulating catecholamines 
concentrations were related to stress-induced changes in lymphoproliferation.
Chapter six summarizes results from experiments which tested in vitro effects of 
norepinephrine, epinephrine, and adrenergic agonists on proliferation o f equine PBMCs 
collected from resting horses. The objective o f these experiments was to clarify our
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understanding o f catecholamine effects on equine PBMCs. Use o f  various agonists was 
expected to provide preliminary information on the type o f adrenergic receptor and related 
second messenger which may be involved in adrenergic effects.
The last experiment was done to measure cortisol and lymphoproliferation at 
various time points in chronically stressed and unstressed ponies. This experiment was 
done to determine if there was a relationship between hormone secretion and 
lymphoproliferation.
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CHAPTER m : MATERIALS AND METHODS
This chapter describes experimental subjects and methods used throughout the 
project. The project included four different experiments which were started in the summer 
of 1992 and completed in the fall o f 1994. Each experiment is discussed in a separate 
chapter. Details regarding materials and methods used only in an individual experiment 
will be described in the related chapter.
A. Animals
These experiments included seven horses and eight ponies. The first part o f the 
project included horses as experimental subjects and the last experiment used ponies. The 
materials and methods for horses, and assays used to assess experimental endpoints in 
both horses and ponies, are described in this chapter. Details pertinent only to materials 
and methods which apply to ponies are described in Chapter seven. Use of horses and 
ponies for these experiments was reviewed and approved by the Louisiana State 
University Institutional Animal Care and Use Committee.
1. Treadmill conditions
A Mustang 2200 high performance equine treadmill (Kagra Intl. Inc., Fahrwangen, 
Switzerland) was used for acclimation, psychological stress tests, and exercise stress tests. 
Heart rate was assessed during exercise stress tests using an on board heart rate monitor 
(Hippocard PEH2000, Bioengineering, Zurich, Switzerland). Speed and incline o f the 
treadmill was controlled manually and the treadmill system was maintained in an enclosed 
room.
41
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2. Horses
Thoroughbred horses were used during the course o f  tiiis study. These horses 
were trained and handled as race horses prior to being donated to the university. Horses 
were maintained on pasture and fed 10 quarts o f Omalene pellets (Purina Mills, St. Louis, 
MO) at 8:00 AM and 4:00 PM. Water was supplied ad-libitum. All horses were 
vaccinated intramuscularly with inactivated influenza A/equine/H3N8 and influenza 
A/equine/H7N7 strains (Fort Dodge, IA). Each horse received 2 vaccinations, 14 days 
apart, as recommended by the manufacturer. Vaccines were administered by a licensed 
veterinarian on an annual basis in the month of January and resident veterinary care 
provided regular deworming and farrier work throughout the project. The age, sex, and 
order of experimental procedures performed on the horses are summarized in Table 1.
The horses were 6 to 11 years old at the beginning o f the experiments. There were 
four mares and four geldings. Geldings were castrated at least two years before they were 
included in the project. Horses were used for experiments performed from June of 1992 
until July o f 1993.
Two o f the horses (#102 and #20) were dropped from the project after the 
experiments were started due to the development o f health problems or injury. Horse 
#102 was included only in the minimal exercise stress test and was not used further due to 
a leg injury. Horse #20 was excluded from the last exercise stress test due to health 
problems. Finally, horse #108 and #135 had been used in exercise conditioning 
experiments performed in 1991. These two horses were included in the present study
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Table 1: Age, Sex, and Order of Experimental Procedures Performed on Horses
Horse identification #
#16 #20 #59 #83 #102 #108 #135 #138
Sex M G M M G G G M
Age (yrs) S 11 7 7 11 11 7 6
Vac (1/91, 92, 93) X X X X X X X X
Accl (3/92) X X X X X X X X
RA (6/92) X X X X
MES(2/93) X X X X X X X X
SG (2/93) X X X X X X X
SS (3/93) X X X X X X X
SP (3/93) X X X X X X X
FG (5/93) X X X X X X
IV (6/93) X X X X
This table gives a brief account o f experimental details pertinent to the use o f horses in the 
project. Dates o f the various stress tests, immunological assays, endocrine assays, and 
receptor binding assays are listed chronologically. Horse identification numbers are listed 
in the top row. Sex o f the animal is indicated by M (mare) or G (gelding). The age for 
each horse corresponds to the age at the beginning o f the experiments (1992). Presence 
of a x in the box indicates that the horse was used in a particular experiment. A blank box 
indicates that a horse was not included in an experiment. Vac = vaccination, Accl = 
acclimation period, RA = cortisol receptor assay; SS = sham/stalled stress, SP = 
sham/psychological stress, MES = minimal exercise stress, SG = slow gallop/moderate 
exercise stress, FG= fast gallop/intense exercise stress, IV = in vitro analysis of 
lymphoproliferation in the presence of native catecholamines and catecholaminergic 
agonists.
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since they appeared unconditioned based on various physiological parameters including 
exercise-induced changes in heart rate, blood lactate, and in vitro lymphoproliferation.
Each horse was subjected to an acclimation period. During this period the horses 
walked and trotted on the treadmill. Horses were subjected to five different stress tests 
which included a sham/stalled, sham/psychological, minimal exercise, slow 
gallop/moderate exercise, and a fast gallop/intense exercise test. The sham/stalled stress 
test was done to obtain baseline data for various experimental endpoints. This test was 
performed on horses that stood in box stalls. This test was started at 6:00 AM and ended 
at 9:00 AM. Two to three horses were tested per day, so that it took three days to 
complete the test.
The sham/psychological stress test was performed where horses stood on a 
stationary treadmill. The horses anticipated exercise, as they were acclimated to regular 
exercise on the treadmill. The sham/psychological stress test was done to see if anxiety 
related to anticipation o f exercise had any effect on our experimental endpoints. The tests 
were started at 6:00 AM and the last sample from the last horse was collected at 10:00 
AM.
The minimal exercise stress test utilized a protocol where horses were walked on 
the treadmill for 2 minutes at 2 meters (m)/second (s), trotted for 3 minutes at 4 m/s, and 
walked for 3 minutes at 2 m/s. The minimal exercise stress test was done to determine 
whether low-level physical exertion effected our experimental endpoints. The tests were 
started at 6:00 AM and they ended at 10:00 AM when the last sample was collected from 
the last horse.
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The slow gallop/moderate exercise stress test consisted o f a 2 minute walk at 1.5 
m/s, a 3 minute trot at 3.5 m/s, a 3 minute gallop at 8 m/s, a 5 minute gallop (8 m/s) on a 
7% incline, and a 2 minute trot at 3.5 m/s. This test was done to determine whether an 
increase in exercise intensity would lead to significant changes in endocrine and 
immunological endpoints. The tests were started at 6:00 AM and ended when the last 
sample was collected from the last horse at 10:00 AM on each day o f the stress test.
Finally, a fast gallop/intense exercise stress test was performed where horses were 
walked for 2 minutes at 1.5 m/s, followed by a 3 minute trot at 3.5 m/s, a 3 minute gallop 
at 10 m/s, a 5 minute gallop (10 m/s) on a 7% incline, and a 2 minute trot at 3.5 m/s. The 
tests were started at 6:00 AM and completed by 10:00 AM on each day o f the experiment. 
This stress test differs from the slow gallop/moderate exercise stress test since the gallop 
speed was increased by 2 m/s. The fast gallop/intense exercise stress test was performed 
since the slow gallop/moderate exercise stress test did not significantly elevate heart rate 
or alter immunological endpoints.
The minimal exercise and slow gallop/moderate exercise stress tests were 
performed in a Latin square cross-over design. Sham/stalled stress and 
sham/psychological stress tests were also performed in a Latin square cross-over design 
whereas the fast gallop/intense exercise stress test was the last experiment that used the 
horses. Dates that specific animals were used in each stress test are listed in Table 2.
Pre-test handling was the same for all the horses. Specifically, horses were housed 
in box stalls overnight before each stress test. They were fed and watered for the day
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before each stress test. On the day of the stress test, food and water were withheld until 
the last sample was collected.
Each horse spent about 25 minutes on the treadmill during the sham/psychological 
or exercise stress tests. All horses that were subjected to exercise stress were washed and 
allowed to cool down for about 15 minutes after they got off the treadmill. They were 
stalled until the last sample was collected from all o f the horses in the test.
B. Blood Sample Collection and Analysis
Blood was collected during each of the exercise and sham stress tests and when 
animals were in their stalls or on pasture. All blood samples were aseptically collected 
into vacutainer tubes (Becton Dickinson, Rutherford, NJ). Multiple sample 18 G needles 
were used to collect blood samples by jugular venipuncture from the resting animals in 
their stalls or on pasture. Blood samples from the animals subjected to the exercise stress 
or sham stress tests were collected via an indwelling jugular catheter. Blood samples were 
used to quantitate cortisol and catecholamines in the plasma and serum, respectively. 
Glucocorticoid receptors in peripheral blood mononuclear cells (PBMCs) were measured 
using blood samples collected from horses. Immunological assays included measurement 
o f pokeweed mitogen (PWM), phytohaemagglutinin (PHA), and equine influenza virus 
(ElV)-induced lymphoproliferative responses o f PBMCs recovered from the blood 
samples collected from horses and ponies.
1. Immunological Assays
Blood samples for immunological assays were aseptically collected into 20 ml 
heparinized (10 U/ml of blood) vacutainer tubes (Becton Dickinson). Sampling time 
points will be discussed for each individual experiment.
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a. Recovery o f PBMCs. Vacutainer tubes were centrifugated at 750 x g 
for 10 minutes to obtain bufiy coats. Buffy coats were diluted in 30 mis o f calcium and 
magnesium-free phosphate buffered saline (CMF- PBS; 0.01 M sodium phosphate, 0.9% 
NaCl, pH=7.4). This suspension was layered onto 10 ml o f  Ficoll-Paque (Pharmacia LKB 
Biotechnology, Piscataway, NJ) and tubes centrifuged at 600 x g for 30 minutes. The 
Ficoll-PBS interface o f PBMCs was collected. Peripheral blood mononuclear cells were 
resuspended in CMF-PBS and pelleted by centrifuging at 600 x g for 10 minutes and twice 
at 150 x g for 10 minutes after the pelleted cells were resuspended in CMF-PBS.
Peripheral blood mononuclear cells were counted on a hemocytometer for further analysis.
b. Mitogen-induced lymphoproliferation. Triplicates or quadruplicates o f 
2 x 10s PBMCs/well were incubated in a final volume o f 0.2 ml in 96 well round bottomed 
plates (Coming Glass Works, Coming, NY). Cells were incubated with 2 ug PWM 
(GEBCO/BRL, Gaithersburg, MD) or 2 ug PHA (GIBCO/BRL) per ml of culture media. 
The plated cells were incubated at 39° C with 5% CO, for 5 or 7 days. Controls included 
PBMCs diluted in RPMI 1640 media (GEBCO/BRL) supplemented with 5% (v/v) horse 
serum (Atlanta Biologicals, Atlanta, GA), 1% (v/v) glutamine (GEBCO/BRL), 1% (v/v) 
10,000 U/ml pencillin, 1% (v/v) 10 mg/ml streptomycin (Pfizer, New York, NY), 20mM 
HEPES (Sigma Chemical Co, St. Louis, MO), and 2 x l0 ‘7 M 2-mercaptoethanol (Sigma 
Chemical Co). Cultures were incubated with 0.5 pCi 3H-thymidine (New England 
Nuclear, Boston, MA) for 4 hours on days 5 or 7. Peripheral blood mononuclear cells 
were harvested onto glass fiber filter paper and counted in a liquid scintillation counter 
(Pharmacia LKB Biotechnology). Lymphoproliferation was recorded as the stimulation
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index. The stimulation index was calculated by dividing the counts per minute (cpm) 
measured for mitogen treated cells by the cpm measured for unstimulated cells from the 
same horse (media control).
c. Equine influenza virus-specific lymphoproliferation. Equine influenza 
virus A (type 2) was propagated in embryonated chicken eggs and harvested allantoic fluid 
was stored at -70° C until use. This EIV stock contained 160 hemagglutination (HA) 
units (U) per ml.
Replicates o f  2 x 10s PBMCs/well were incubated with 1.6 HA U (dose 1) or 16 
HA U (dose 2) for 5 or 7 days. Media used in the assay was the same as that for the 
mitogen-induced lymphoproliferation studies. Controls included PBMCs and media. The 
final volume in each well was 0.2 ml and cultures were incubated at 39° C and with 5% 
C 0 2. On days 5 and 7 o f incubation, PBMCs were incubated with 0.5 pCi o f 3H- 
thymidine for four hours. Cells were harvested onto glass fiber filter paper and counted in 
a liquid scintillation counter. Specific lymphoproliferation was recorded as the stimulation 
index.
2. Hormone Assays
All blood samples for cortisol quantitation were collected into 10 or 20 ml 
heparinized Vacutainer tubes (Becton Dickinson). Blood samples used for catecholamine 
assays were collected into 7 ml EDTA Vacutainer tubes (Becton Dickinson) after 100 pi 
o f a 420 mg/ml glutathione (Sigma Chemical Co.) solution was added to each tube. 
Sampling time points will be discussed separately in individual chapters.
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a. Cortisol radioimmunoassays. Blood samples were centrifuged at 750 x 
g, for 10 minutes, immediately following collection. Plasma was pipetted into 
microcentrifuge tubes as 1.5 ml aliquots which were snap frozen on dry ice. Samples were 
stored at -80° C until the time of radioimmunoassay (RIA).
One hundred microliter aliquots o f  the thawed plasma samples were extracted with 
2 mis o f  acetone (ACS, PVC, CTD, Mallinckrodt Inc., Paris, Kentucky). The extracts 
were dried and then reconstituted in 500 pi ofPBS-gelatin (PBS-Gel; 0.01 M sodium 
phosphate, 0.9% NaCl, 0.097% NaN3, 0.1% gelatin; pH=7.3). Triplicate 100 ul aliquots 
o f the reconstituted extracts were assayed. The cortisol antiserum (LSU-R17) was a gift 
from Dr. Donald Thompson, Jr. (Louisiana State University, Baton Rouge, LA). This 
antibody has been characterized and validated for analysis o f equine samples (133).
Assays were done as described by Thompson and coworkers (133) using tritiated cortisol 
(specific activity 1.0 mCi/ml; Dupont, MD) as the radioactive ligand (24,000 cpm/tube).
A standard curve was generated by graphing results for 9 serially diluted cortisol (Sigma 
Chemical Co.) standards ranging from 6000 to 31.25 pg/ml. Replicate low (75 pg/100 ul) 
and high (225 pg/100 ul) internal standards were run to check the accuracy of the assay 
and to calculate inter- and intra-assay variation. Non-specific binding was tested with 
PBS-Gel.
Radioimmunoassay tubes were incubated at 4° C for 24 hours. Radioactive 
cortisol was quantitated after absorbing unbound cortisol with charcoal. This was done by 
incubating each tube with 500 ul o f 1% (w/v) neutralized, activated charcoal in PBS-Gel 
and centrifuging the assay tubes at 3000 rpm for 10 minutes. The resulting supernatant
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was mixed with 2.5 mis o f liquid scintillation cocktail (Ultima Gold™, Packard Instrument 
Company, Meriden, CT) and radioactivity was measured in cpm on a Packard liquid 
scintillation counter.
b. Catecholamine assay. Catecholamines in equine blood samples were 
measured as previously described by our laboratory (127). Briefly, blood samples were 
centrifuged at 750 x g for 10 minutes immediately after their collection. Serum was 
pipetted into microcentrifiige tubes as 1.5 ml aliquots and snap frozen on dry ice. Serum 
samples were stored at -80° C for subsequent analysis. Samples were thawed to room 
temperature and 100 pi o f serum was diluted with 300 pi of running buffer. The running 
buffer included 3.35g monocholoroacetic acid, 5.3g NaH2P 0 4H20 , and 0.5g sodium 
dodecycl sulphate dissolved in 720 ml deionized distilled water, 200 ml acetylnitrile, and 
80 ml methanol. Buffer was adjusted to a pH o f 3.0-3.5. This buffer was filtered twice 
through 0.22 pm pore size filters (Millipore Corporation, Bedford, MA). Diluted samples 
were then filtered through non-sterile Ultra ffee-MC filter units (MW c.o=5000, # uF 
C3LCCOO, Millipore Corp.). The sample filtrate was stored at 4° C until monoamine
quantification.
Monoamines were resolved by high performance liquid chromatography (HPLC).
A Hewlett Packard 1090 liquid chromatograph with an absorbosphere Clg reverse phase 
column (Alltech Associates, Inc., Deerfield, EL), protected by a guard column (VYDAC 
201 IP Clg 300A), was used for HPLC. A single Hewlett Packard 1049A electrochemical 
detector, set at 700 mV, was used to resolve amines. The running buffer described in the 
preceding paragraph was used as the mobile phase. Retention times for norepinephrine
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
and epinephrine were approximately 5 and 10 minutes, respectively. Three, four- 
dihydroxybcnzyiamine hydrobromide (Sigma Chemical Co.) was used as an internal 
standard.
C. Statistical Analysis
All assays were done with triplicate or quadripulicate replications of each sample 
A statistical analysis system (SAS) on a personal computer and on the university main 
frame computer were used for each analyses. P-values o f  <0.05 were considered 
significant for all assays. Specific statistics that were used to analyze results from 
individual experiments will be described in the related chapters.
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CHAPTER IV: DIURNAL CHANGES IN SPECIFIC BINDING OF CORTISOL 
TO CYTOSOLIC AND NUCLEAR FRACTIONS FROM EQUINE PERIPHERAL
BLOOD MONONUCLEAR CELLS
A. Introduction
Stress is related to release of multiple hormones and neurotransmitters and it has a 
wide range o f effects on the immune system. A particular stressor may increase leukocyte 
concentrations, alter the peripheral distribution o f leukocytes, produce lymphopenia, 
decrease helper cell subsets, increase monocyte populations, increase natural killer (NK) 
cell activity, decrease immunoglobulin concentrations, decrease interleukin (IL)-l 
secretion, increase IL-6 secretion, and increase killing of NK cell resistant targets by 
lymphokine activated killer (LAK) cells (83, 182 - 184).
Glucocorticoids effect almost all eukaryotic cells due to the wide-spread 
distribution o f the related receptor (75) and high concentrations of these steroids have 
potent inhibitory effects on various immune functions (185). Hormone binding to 
glucocorticoid receptors (GR) activates the receptor and increases its affinity for 
chromatin (75). Hormone-bound GR binds to glucocorticoid response elements (GREs) 
which regulate transcription of various genes. Glucocorticoid effects may also involve 
binding to GREs that overlap binding sites for cAMP responsive element binding protein 
(CREB); thereby preventing the effectiveness o f cAMP cascades. Hormone occupied GR 
may also bind to subunits o f activator protein-1 (AP-l) which blocks the transcription of 
genes that are dependent on stimulation by AP-l nuclear proteins (76, 77). Molecular 
interactions between multiple signaling systems is a contemporary research area that is
53
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likely to be important to our general understanding of neuroimmunology and clinical 
management o f  stress-dependent reductions in various immune functions. Characterizing 
the time points when GR are available for interactions with other nuclear proteins will 
provide a basis for subsequent experiments on cross-talk between GR and other second 
messengers.
The equine species exhibits diurnal fluctuations in plasma cortisol concentrations 
(13, 73). These hormone fluctuations are likely to result in alterations in hormone- 
occupied GR that are available for interactions with GREs and various nuclear proteins. 
This possibility is supported by diurnal fluctuations of GR in human and rat peripheral 
blood mononuclear cells (PBMCs) (186). Similar studies have not been reported for the 
equine species.
Cortisol binding to GR in cytosolic and nuclear fractions o f equine PBMCs was 
measured in this experiment in order to gain a better understanding of receptor dynamics 
and verify that specific GR are present in equine PBMCs. Changes in subcellular 
concentrations of GR may be of particular interest in light o f diurnal fluctuations in 
cortisol secretion as well as differences in the hormonal and immunological response 
during morning and evening times o f the day (4, 73).
B. Materials and Methods
I. Horses
Four unconditioned horses were used for this experiment. The description and 
maintenance of these horses were specified in Chapter three.
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2. Sample Collection and Fractionization o f  Nuclear and Cytosolic Protein
a. Sample collection. Blood samples were collected aseptically into 20 ml 
heparinized (10 U/ml o f blood) Vacutainer tubes (Becton Dickinson., Rutherford, NJ) by 
jugular venipuncture from resting horses. Horses were on pasture when samples were 
collected to validate the cortisol receptor assays. Samples collected at 8 AM and 2PM 
were used to validate assays. Samples were subsequently collected at six hour intervals 
(8 AM, 2PM, 8PM, 2AM) in order to measure any diurnal variations of cortisol binding to 
nuclear and cytosolic fractions. Horses were housed in open air stalls when blood samples 
were collected at 6 hour intervals.
The PBMCs were recovered as described in Chapter three. Cells were washed 
with 5 ml o f  ice cold TEMGD buffer [10 mM Tris, 1.5 mM EDTA, 25 mM molybdate,
10% (v/v) glycerol, and 1 mM dithiothreitol (pH =7.4)]. Centrifugation was used to 
recover cell pellets and pelleted samples were snap frozen and stored at -85°C.
b. Fractionization of nuclear and cytosolic protein. Pelleted cells were 
suspended in 1 ml o f ice-cold TEMGD buffer per 6.0 x 107 cells. The PBMCs were 
briefly homogenized with a polytron and homogenates were centrifuged at 700 x g and 
4°C for one hour. The resulting supernatants were used to measure specific binding to 
cytosolic fractions. Pellets from homogenized PBMCs were diluted in 1 ml o f ice-cold 
TEMGD buffer per 6.0 x 107 cells. This fraction was used for contemporary analysis o f  
binding to nuclear GR.
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3. Validation o f Receptor Binding Assays
Initial binding studies were based on commonly used steroid receptor assays 
previously tested by our laboratory to analyze estrogen and progesterone receptors (187). 
Preliminary experiments characterized: (a) time-dependent specific binding o f radiolabeled 
cortisol to cytosolic preparations; (b) saturation o f  specific binding with variable 
radioligand concentrations; (c) linear binding to different protein concentrations; and (d) 
loss o f specific binding in heat-treated samples.
a. Time-dependent specific binding o f radiolabeled cortisol to cytosolic 
preparations. Fractions from 6.0 x 107 PBMCs were incubated with 500 fmoles (fM) o f 
tritiated cortisol (specific activity lpCi/pl, New England Nuclear, Boston, MA) in the 
presence or absence o f 1000 nM dexamethasone (Sigma Chemical Co., St. Louis, MO). 
Reagents were diluted in TEMGD buffer. Assay volume was standardized to 400 pi with 
TEMGD buffer and tubes were incubated at 4°C. Specific and non-specific binding were 
measured at 0, 5, 10, 15, 20, 25, and 30 hours after the beginning o f incubation. Unbound 
hormone was removed by incubating samples with 400 pi o f 1% (w/v) charcoal in PBS- 
gel (0.005 M mono and 0.005 M dibasic sodium phosphate, 0.9% NaCl, 0.2% gel, pH 
7.4) for 15 minutes at 4°C. Samples were subsequently centrifuged (700 x g) for 20 
minutes at 0° C. Bound radioactivity in the resulting supernatant was counted on a 
Packard liquid scintillation counter after mixing samples with 2.5 ml o f Ultima Gold 
scintillation cocktail (Packard Instrument Co., Meriden, CT). The assay also included two 
sets o f tubes containing 300 ul o f TEMGD buffer and 500 fM of tritiated cortisol. One set 
was processed to separate bound and unbound hormone for purposes o f determining the
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non-specific binding. The second set was used to determine total radioactivity. The cpm 
measured for each sample were calculated as fM bound per 10s PBMCs. This was 
possible since radiolabeled cortisol added to each assay tube contained a known number o f 
moles. Total and specific binding were plotted to evaluate binding at various time points.
b. Saturation o f specific binding with variable radioligand concentrations. 
Saturable-specific receptor binding was demonstrated by incubating protein from 6.0 x 107 
PBMCs with 156.35, 312.50, 625, 1250, 2500, or 5000 fM o f tritiated cortisol in the 
presence or absence o f excess unlabeled dexamethasone. The volume in each tube was 
brought up to 400 pi with TEMGD buffer. Assays were incubated at 4°C for 10 hours. 
Bound and unbound fractions were separated as described above. Radioactivity in the 
supernatant was plotted to evaluate linear and saturable binding. Intra- and inter-assay 
variation were less than or equal to 10%.
c. Linear binding to different protein concentrations. Linear binding was 
tested using 25, 50, 75, 100, 150, and 200 ug of protein from PBMCs. Protein 
concentrations were measured using the Pierce micro BCA protein assay reagent kit 
(Pierce, Rochford, IL) and standard protocols described by the manufacturer. Protein 
concentrations in each tube were prepared from 1.0 x 106 to 1.0 x 10* PBMCs. Cytosolic 
protein fractions were incubated at 4°C for 10 hours with 500 fM of tritiated cortisol. 
Replicates were incubated with and without 1000 nM dexamethasone. Free and bound 
hormone separation was performed as mentioned above. Plots o f results for each horse 
were evaluated separately. An internal standard prepared from a pool o f PBMC extracts 
was used to evaluate assay variability which was less than 10%.
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d. Loss o f specific binding in heat-treated samples. Heat lability o f 
receptor protein was confirmed by heating cytosolic fractions from 6.0 x 107 PBMCs to 
60°C for 15 minutes. Untreated replicate cytosolic fractions were tested for binding as a 
contemporary control. Triplicate aliquots o f control and heat treated cytosolic protein 
were incubated with 3500 fM o f tritiated cortisol in the presence or absence o f  excess 
dexamethasone. Samples were incubated at 4° C for 10 hours. Separation o f bound and 
free hormone was done as described above.
4. Diurnal Variation o f Cortisol Binding to Nuclear and Cytosolic Fractions
Samples from 4 horses were assayed in triplicate. The assay volume was 400 ul 
per tube which included 3500 fM of tritiated cortisol and 100 ul o f cell protein extracted 
from 6.0 x 106 PBMCs and suspended in TEMGD buffer. The number o f cells used was 
based on the cell number which consistently yielded protein concentrations that exhibited 
linear specific binding to radiolabeled cortisol. Samples were incubated at 4° C for 10 hrs. 
Free and bound hormone were separated as described above. Specific binding was 
measured as radiolabeled cortisol displaced by 1000 nM dexamethasone. Specific binding 
is expressed as fM o f hormone bound based on known molar concentrations o f radioactive 
hormone in contemporary total count tubes. Data for the samples were standardized as 
fM specifically bound per 106 PBMCs. These values were analyzed by one way ANOVA 
and pairwise comparisons were done using LSD.
C. Results
Validation assays demonstrated time-dependent, saturable-specific binding that 
was abolished by heat treatment o f the receptor fractions. Specific binding to protein
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incubated for various time periods (Figure 7) increased from 0 (0.002 fM/106 cells) to 5 
(0.050 fM/106 cells) hours and from 5 to 10 (0.070 fM/106 cells) hours. Binding in 
fractions incubated for 15 (0.020 fM/ 106 cells), 20 (0 fM/106 cells), 25 (0 fM/106 cells), 
and 30 (0 fM/106 cells) hours was markedly reduced.
Linear binding was demonstrated for protein concentrations ranging from 75 to 
200 pg (Figure 8). Specific binding to 75, 100, 150, and 200 pg was 2.32, 5.70, 8.40, and 
12.3 fM respectively. Regression analysis of the data demonstrated a positive linear 
relationship (P = 0.0024; R2 = 0.9214) When linear binding was evaluated for PBMCs 
collected at various time-points and from different horses (n=4), protein concentrations o f 
100, 150, and 200 ug consistently exhibited linear binding. This amount o f protein was 
recovered from 4.5 x 106 to 1.0 x 10* PBMCs.
Saturable specific binding was observed when tubes were incubated with 2500 to 
5000 fM of radiolabeled cortisol (Figure 9). However, the amount of hormone bound 
represented a small fraction o f the radiolabeled hormone concentration. Cells incubated 
with 156.35, 3 12.50, 625, 1250, 2500, or 5000 fM of tritiated cortisol bound 0.037,
0.020, 0.060, 0.070, 0.150, and 0.160 fM of cortisol per 106 PBMCs, respectively.
Binding to control fractions (0.05 fM/106 PBMCs) was abolished (0 fM/106 PBMCs) 
when replicates were heated to 60° C for 15 minutes.
Table 3 lists specific binding (mean + SE) to nuclear and cytosolic fractions and 
total binding for samples collected at various time points. Binding to the cytosolic fraction 
was lower (P<005) at 8AM than binding to samples collected at 2PM. Binding at 8 AM 
was also lower (P<.025) than binding to cytosolic fractions prepared from cells collected

















Figure 7: Time dependent binding of radioactive cortisol to PBMC fractions.
Protein fractions from 6.0 x 107 PBMCs were incubated with tritiated cortisol in the 
presence or absence o f excess dexamethasone. Specific and non-specific binding were 
measured at 0, 5, 15, 20, 25, and 30 hours of incubation.
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Protein (jig)
Figure 8: Linear binding of radiolabeled cortisol to PBMC fractions. Protein 
concentrations were prepared from 1.0 x 106 to 1.0 x 10s PBMCs. Fractions were 
incubated with and without excess dexamethasone. Regression analysis was used to 
determine that there was a linear relationship between binding and protein concentrations 
ranging from 75 to 200 pg.
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Figure 9: Saturable specific binding of cortisol to PBMC fractions. Saturable 
specific binding was demonstrated by incubating protein from 6.0 x 107 PBMCs with 
tritiated cortisol in the presence or absence o f excess unlabeled dexamethasone. Specific 
binding was abolished when cell fractions were heated to 60° C for 15 minutes as 
compared to binding measured for controls. Specific binding was saturated for protein 
concentrations ranging from 2500 to 5000 fM.

















Table 3: Specific Binding of Radiolabeled Cortisol to PBMC Fractions 
Collected Throughout the Day





8 AM 0.50 ± 0.40* 10.10 ± 4.91 10.60 ± 2.31
2 PM 6.45 ± 0.051’ 12.70 ± 9.93 19.15± 4.21*
8 PM 5.70 ± 1.56h 6.10 ± 0.12c 11.80 ±0.67
2 AM 8.10 ± 1.34" 0.00 ± 0.00d 8.10 ± t.56r
M e a n s  (±  S E )  w ith in  a c o lu m n  that a re  labe led  w ith  d ifferen t le t te rs  o f  a pa ir  (a, b; c, d; e  , 0  a re  s ta tis tically  ( P < 0 .0 5 )  d ifferent. 
M e a n s  w ith o u t  le t te r  su p e r s c r ip t s  w e re  no t s ign if ican tly  d ifferen t f rom  o th e r  m ean s  w ith in  a co lum n .
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at 8PM and 2AM. Binding to nuclear fractions was higher (P<0.05) at 8 PM than at 
2AM. Total binding was higher (P<0.05) at 2PM than binding to samples collected at 
2 AM. Total binding at 8 AM, 8PM, and 2AM was approximately 50% of that measured 
for PBMCs collected at 2PM.
D. Discussion
Steroid receptors available for hormone binding are believed to be associated with 
the outer nuclear membrane (75). These receptors end up in cytosolic fractions when cells 
are prepared for standard steroid receptor assays. Hormone-occupied steroid receptors 
interact with various nuclear proteins (76, 188). Thus, it is o f interest to determine 
whether nuclear GR is present in immune cells when plasma concentrations of cortisol are 
reduced. In the case o f the equine species, cortisol peaks in the early morning hours 
between 8 and 10 AM (13, 73). It subsequently declines and reaches low levels during the 
night. In the present study, we were unable to detect GR in nuclear fractions collected at 
2 AM. This was true for all horses. It suggests that stimuli which act through cAMP 
and/or protein kinase pathways would not be subject to dampening effects o f nuclear GR 
in the early morning hours. On the other hand, it has not been determined how much 
glucocorticoid is needed for net effects on transcription in equine PBMCs. Thus, it is not 
clear whether nuclear GR found at 8 PM is active in this regard. Peak specific binding of 
cortisol to nuclear GR at 8 AM and 2 PM suggests that these time points are likely to be 
related to glucocorticoid-dependent protein synthesis by equine PBMCs. This assumption 
is supported by glucocorticoid effects on protein synthesis in PBMCs for other species 
(189). Equine immune cell proteins regulated by glucocorticoids have not been isolated.
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Cytosolic GR measured in the present study was low when cortisol concentrations 
peak in equine plasma. Specific binding to cytosolic fractions increased throughout the 
day. This would be expected based on the shuttling o f steroid receptors that occurs 
following increased plasma concentrations o f steroid and steroid binding to the receptor 
(186). It is also consistent with diurnal changes in GR receptor binding reported for 
rodent and human PBMCs (186).
Total binding o f cortisol to equine PBMCs peaked at 2 PM. High concentrations 
o f  nuclear GR were found at the same time and cytosolic GR at 2 PM was higher than that 
at 8 AM. However, total binding at 8 AM, 8 PM, and 2 AM were similar. This implies 
that early morning increases in cortisol, and the related translocation o f GR to the nucleus, 
may also stimulate GR synthesis. Glucocorticoids have been reported to up-regulate their 
receptors in certain cells from humans (190). Whether this occurs in equine PBMCs will 
require further study.
Results for rats and humans have indicated that immune cell GR is identical to that 
found in other tissues (186). Nuclear protein extracts from equine PBMCs contain a 
protein with a molecular weight comparable to GR in other species and the protein from 
equine PBMCs specifically binds monoclonal antibodies directed against conserved DNA 
binding sequences in GR (73). This would suggest that structure o f GR in the equine 
species is similar to that which has been characterized for other species. However, it 
should be noted that the time-dependent binding demonstrated in the present study was 
rather unexpected. Peak binding occurred after 10 hours for fractions o f equine PBMCs. 
Thereafter, it seemed that the receptor was rapidly broken down. Similar studies with
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progesterone and estrogen receptors have indicated that optimal binding is usually 
observed at 15 to 18 hours when assay conditions are similar to those used in the present 
study (187). This time is fairly standard for steroid hormone receptor assays. Why the 
binding o f cortisol to equine PBMCs appears to be more labile is not known. However, it 
may be that modifications added for processing large numbers o f  samples necessary for 
this experiment and related impurities in the cytosolic fractions contributed to enzymatic 
degradation o f GR. The same factors may explain why such small amounts of cortisol 
were bound to fractions from equine PBMCs.
In many cell types biological effects o f glucocorticoids depend on the number of 
receptors and their responsiveness to glucocorticoids (185). In humans and other species, 
different stressors, including exercise stress, induce a significant decrease in GR binding 
capacity (185). This suggests that target cell responsiveness to glucocorticoids may 
decrease after stress due to a reduction in GR synthesis, increased degradation o f GR, 
and/or inhibition o f receptor activation. In order to elucidate mechanisms responsible for 
stress-induced effects o f glucocorticoids, the kinetics o f GR in various physiological 
conditions needs to be more clearly defined. Published literature (185, 186), and results 
from the present experiment, suggest that multiple regulatory processes probably function 
to control the amount o f available GR in various cellular compartments.
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CHAPTER V: RELATIONSHIP BETWEEN EXERCISE-STRESS-INDUCED 
CHANGES IN LYMPHOPROLIFERATION AND CIRCULATING 
CATECHOLAMINE CONCENTRATIONS IN HORSES
A. Introduction
Research on neuroendocrine-immune interactions has indicated that diverse 
stressors alter immunological functions (4, 9, 52, 119, 182, 191 - 193). The effect of 
exercise on the immune system varies with the type, duration, and intensity o f physical 
exertion (171, 191). Intense exercise effects a variety o f immune functions. Changes in 
function o f the immune system following intense exercise stress reportedly include 
decreased T and B cell responses to mitogenic stimulation, alterations in CD4:CD8 ratios, 
and alterations in natural killer (NK) cell activity (171). A moderate exercise program 
decreased mitogen-induced proliferation in laboratory mice (191). Immunomodulation 
resulting from moderate exercise has been related to stress-dependent catecholamine 
release in humans (194). Such catecholamine release probably plays a major role in 
initiating immune changes by acting through adrenergic receptors (21, 84).
Inhibition o f T-cell proliferation depends on circulating concentrations of 
catecholamines after exercise and the number of adrenergic receptors on human 
lymphocytes (190). Catecholamine concentrations depend on the duration and type of 
stress experienced by human subjects, but the largest increase in catecholamine release 
occurred after strenuous work (190). Increased catecholamine concentrations after 
submaximal bicycle exercise have been associated with increased numbers of granulocytes, 
lymphocytes, NK cells, and B cells, as well as changes in lymphocyte subsets (10,52,
67
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194). The effects o f bicycle exercise on these immune parameters were more pronounced 
when individuals suffered from emotional strain (195). Epinephrine injection modified 
immune functions in a similar manner except that increased B cells were measured 
following exogenous administration o f this amine to human subjects (196). Response o f 
individuals to stress varies considerably for reasons which have not yet been clearly 
elucidated.
Studies on exercise-induced changes in immune function have largely been based 
on two models. Acute stress test models typically include individuals subjected to a single 
bout o f exercise and neuroendocrine-immune interactions are studied before and after the 
stress test (178). Chronic exercise stress models have been used to study the incidence o f 
disease in elite athletes and neuroendocrinological and immunological endpoints have 
generally been analyzed in relationship to disease episodes (177). Very little is known 
about the effects o f chronic moderate exercise programs on immune function. Significant 
progress in this research area will require a model that takes into account physical and 
psychological factors that influence exercise activity and neuroendocrine-immune 
interactions.
Equine influenza A virus is a major cause o f respiratory disease in horses (1).
Most efforts to control epidemics o f equine influenza relay on vaccination programs. 
However, antibody titers induced by vaccination rapidly decline and the protection 
conferred by vaccination is short lived (1). Thus, it is of considerable interest that 
treatment regimes which improve the response to vaccination be identified. Based on 
results from other species, it is conceivable that short-term pharmacological manipulations
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o f catecholaminergic systems might be used in conjunction with vaccination regimes in 
order to enhance primary and/or secondary antibody responses for purposes o f improving 
the protection against influenza infections. The present study was aimed at gaining a 
better understanding o f the relationship between in vivo release of catecholamines and in 
vitro immunological responses to mitogen and influenza virus. Lymphoproliferation was 
tested for peripheral blood mononuclear cells (PBMCs) collected from horses subjected to 
sham, psychological, and exercise stress tests.
B. Materials and Methods
1. Horses
Seven horses were used for these experiments. Description and maintenance of 
horses were described in Chapter three.
2. Stress Test Regimes
Five different stress tests were performed. Details o f each stress test and the 
number o f horses included in each test were described in Chapter three.
3. Sample Collection, Catecholamine Quantification, and Lymphoproliferation
Assays
Samples were collected 60 minutes prior to beginning of each stress test, at the 
beginning of the stress test (0 minutes), and at 5, 10, 15, 30, 45, 60, and 120 minutes after 
the start o f each stress test. A recently validated HPLC method was used to measure 
circulating concentrations o f epinephrine (E) and norepinephrine (NE) at the 
aforementioned time points (197).
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Immunological assays measured equine influenza virus (EIV)- and pokeweed 
mitogen (PWM)-induced lymphoproliferation. These assays were performed as described 
in Chapter three using PBMCs collected at four time points. Samples were collected 60 
minutes before the start o f  each stress test (T^,), and at 13 (T+13), 33 (T+33), and 73 (T .^) 
minutes after the start o f each stress test. Influenza-specific lymphoproliferation was only 
tested with dose 2 EIV (16 HA U) and EIV was incubated with PBMCs for 5 or 7 days. 
Mitogen-induced lymphoproliferation was tested for PBMCs cultured for 5 days in the 
presence o f 2 pg o f pokeweed mitogen (PWM).
4. Statistical Analysis
Samples from each horse were assayed in triplicate. Data were analyzed using 
repeated measure analysis o f variance. Lymphoproliferation results in cpm were 
converted to a percentage of cpm measured for pretreatment (T^j) results. Pairwise 
comparisons (Tukey’s t test) were done to determine whether ElV-specific and/or 
mitogen-induced lymphoproliferation measured during the stress tests were significantly 
different from lymphoproliferation measured for pretreatment samples. Basal and stress- 
induced amine concentrations were also compared using Tukey’s t test. Correlation 
between the circulating catecholamine concentrations and lymphoproliferation was 
analyzed using Pearson and Spearman methods.
C. Results
1. Circulating Concentrations o f Catecholamines in Different Stress Tests
Table 4 lists physiological concentrations (mean ± SE) of amines in samples 
collected from resting and stressed horses. The mean basal concentration o f NE in

















Table. 4: Physiological Concentrations of Amines in Resting and Stressed Ilorses
Stress Tests Norepinephrine (pg//d) Epinephrine (pg//d)
Basal Stress-induced Basal Stress-induced
Sham/stall 67.92 ± 17.06 74.16 ±6.76 79.80 ± 17.19 49.38 ± 6.53
Sham/psych 28.69 ± 9.10 56.14 ± 7.74 41.64 ±6.10 43.98 ± 5.36
Minimal 79.22 ± 11.83 71.02 ±4.02 38.70 ±6.17 44.18 ± 2.37
Slow gallop 147.35 ± 58.29 121.92 ± 17.96 149.13 ±30.97 296.01 ±62.79*
Fast gallop 56.80 ±21.34 46.64 ±5.92 30.34 ±3.88 409.65 ±63.07*
Mean amine concentrations (± SE) are in pg/^1 for samples collected from resting horses (basal) and for samples collected at 5, 
10, 15, 30, 45, and 60 minutes after the start of the stress test. Values for samples collected after the start of the stress test (5 to 
60 minutes) were pooled to calculate mean stress-induced concentrations of amines since there were no significant differences 
between these time points. Significant differences between basal and stress-induced concentrations o f E are marked with an 
asterisk (*). Stress tests included: Sham/Stall (Sham/stalled; n~-6), Sham/psych (Sham/psychological; n=6), Minimal (Minimal 




samples collected before the stress tests was 76.00 ± 18.00 pg/^1. There were no 
significant differences between basal concentrations o f NE measured before the different 
stress tests and stress-induced concentrations o f  NE measured during the sham/stalled, 
sham/psychological, minimal exercise, slow gallop/moderate exercise, and fast 
gallop/intense exercise stress tests.
The mean basal concentration o f E was 67.90 ± 20.10 pg/^1. Epinephrine 
concentrations in equine samples were highly variable at various time points and during 
different stress tests. However, there was about a two to three fold stress-induced 
increase (P<0.05) in the concentrations o f E measured for horses subjected to the slow 
gallop/moderate exercise and fast gallop/intense exercise stress tests. The sham/stalled, 
sham/psychological, and minimal exercise stress tests did not alter (P>0.05) serum E 
concentrations.
2. ElV-specific and Mitogen-induced Lymphoproliferation 
Table 5 summarizes lymphoproliferation data for horses subjected to the different 
stress tests. Influenza-specific lymphoproliferation was significantly increased by the 
sham/stalled stress test. The sham/psychological, minimal exercise, and slow 
gallop/moderate exercise stress tests did not significantly effect ElV-specific 
lymphoproliferation. Data for the fast gallop/intense exercise stress test could not be 
analyzed since the T^, sample was lost during processing.
There was a main effect (P<0.05) o f time and stress test on mitogen-induced 
proliferation. The minimal exercise stress test decreased (P<0.05) PWM-induced 
blastogenesis. The sham/stalled, sham/psychological, and slow gallop/moderate exercise
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Table 5: Lymphoproliferative Response of PBMCs Collected During Different Stress
Tests
Stress Tests Influenza-Specific Lymphoproliferation




5 Day Cultures 7 Day Cultures
Sham/stall 91.75 ±39.66 388.10 ± 143.65' 135.94 ±41.94
Sham/psych 118.73 ±33.98 110.38 ±38.84 176.81 ±53.94
Minimal 280.72 ± 167.47 157.41 ±62.04 18.89 ± 6 .50 '
Slow gallop 62.15 ±9.61 173.15 ± 132.33 100.90 ±43.40
Fast gallop No data No data No data
There was no effect (P>0.05) o f  time on proliferative response of PBMCs collected after 
the start o f the stress tests. The mean cpm of the proliferative response for cells collected 
at T+13 and T+33 was divided by the cpm measured for the lymphoproliferative response of 
PBMCs collected at T ^ . Values in each column are listed as the mean percentage of the 
pretreatment (T ^ ) ± SE. Values that reflect a significant effect o f stress on 
lymphoproliferation are marked with an asterisk (*). The T ^  sample for the fast 
gallop/intense exercise stress test was lost. See legend below Table 4 for a list of 
abbreviations.
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stress tests did not effect (P>0.05) PWM-induced lymphoproliferation. Data for the fast 
gallop/intense exercise stress test could not be evaluated due to loss o f the sample.
3. Relationship o f  Catecholamine Concentrations to Influenza-specific and 
Mitogen-induced Lymphoproliferation for Samples Collected During the Five Different 
Stress Tests
Epinephrine was significantly increased during the slow gallop/moderate exercise 
and the fast gallop/intense exercise stress tests. Lymphoproliferation was not effected by 
the slow gallop/moderate exercise stress test and data was not available to determine 
whether the fast gallop/intense exercise stress test effected lymphoproliferative responses. 
For the data that were available, there was no significant correlation between serum 
catecholamine concentrations and lymphoproliferation.
D. Discussion
Numerous peptides, steroids and amines are released in response to a particular 
stressor (4, 18). However, Selye’s (97) original definition of stress was based on the 
premise that cortisol and catecholamines are always released in response to stress.
Current literature clearly indicates that the amount o f these compounds that is released 
varies depending upon the nature and duration of a stress as well as a number of 
contributing factors. Nevertheless, it is fundamental to our understanding of 
neuroendocrine-immune interactions that we elucidate the role that catecholamines play in 
regulating immune functions.
Interest in catecholaminergic regulation of immune function increased when it was 
reported that stress-induced changes in immunity occur in adrenalectomized and 
hypophysectomized rats (192, 193). Recent reports also indicate that lymphoid tissues are
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innervated by sympathetic nerve fibers and that immunocompetent cells possess high 
affinity adrenergic receptors (37). Catecholamine release caused by physical or 
psychological stress depends on activation o f the CNS and the related response o f  the 
ANS (79). Acute systemic release o f catecholamines during exercise stress has been 
related to reduced lymphoproliferation in murine experimental models (78). Further, 
denervation and/or pharmacological treatments that prevent neurotransmitter release in or 
from the adrenal medulla, thymus, or lymph nodes may alter specific immunological 
functions such as in vivo proliferation o f immune cells in lymph nodes, spleen, and bone 
marrow (21, 80). Chemical sympathectomy also reportedly diminished the primary 
antibody response in mice by as much as 80% and 97% in spleen and lymph nodes, 
respectively. Denervation and/or pharmacological block o f sympathetic transmitter 
release also reduced the secondary antibody response and resulted in a 50% reduction in T 
cell-mediated responses including delayed hypersensitivity to epicutaneous immunization 
and cytotoxic T-lymphocyte response to alloantigens. The same experimental reports 
described enhanced lipopolysaccharide-stimulated proliferation and enhanced 
immunoglobulin production by lymph node cells following denervation or pharmacological 
block of sympathetic activity (37, 80).
Catecholamine concentrations measured before and during the stress tests widely 
fluctuated within and among horses. Norepinephrine concentrations were not significantly 
effected by any stressor. Epinephrine concentrations were elevated two fold when horses 
were subjected to more strenuous physical exertion associated with the slow and fast 
gallop exercise tests. The sham/stalled, sham/psychological, and minimal exercise stress
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tests did not change E concentrations when stress-induced amine concentrations were 
compared to basal concentrations. These results suggest that only the slow 
gallop/moderate exercise and fast gallop/intense exercise groups were stressed based on 
the premise that stressors always cause the release o f glucocorticoids (data not shown) 
and catecholamines from the adrenal gland. These results would also be desirable since it 
was originally proposed that the sham/stalled, sham/psychological, and minimal exercise 
stress tests would serve as controls that would help us determine whether sampling 
procedures and/or behavioral/psychological factors might be confounding results from the 
exercise stress tests.
Data from this experiment indicated that ElV-specific lymphoproliferation was 
increased over baseline in horses subjected to the sham/stalled stress test. Mitogen- 
induced blastogenesis measured in this experiment was inhibited by minimal exercise stress 
and not altered by the other stressors. Keadle (123) previously reported that exercise 
regimes identical to that used for our slow gallop/moderate exercise and our fast 
gallop/intense exercise stress tests inhibited ElV-specific and PWM-induced blastogenesis 
o f equine PBMCs. It is not clear why results from the present project differ from the 
previous report. However, a number o f factors may account for this discrepancy. Firstly, 
effects o f the stress tests on EIV-induced blastogenesis were only observed when PBMCs 
were cultured 7 days in these experiments. There was no effect o f stress on EIV-induced 
proliferation when cells were cultured for 5 days. The effects on PWM-induced 
proliferation in this experiment were found for PBMCs that were cultured 5 days. Keadle 
(123) utilized bulk cultures o f PBMCs and assayed lymphoproliferation on days I, 3, 5, 7,
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and 9. It is unlikely that the effects o f exercise stress on EIV- or mitogen-induced 
blastogenesis were equivalent on each of these days and for the results that were shown 
there was no indication o f the number o f days that the PBMCs had been cultured. Thus, it 
is possible that the apparent discrepancy in our results is because we are reporting results 
for cells cultured for a different number o f days.
Secondly, 1.6 or 16 HA U of EIV stock was used to stimulate equine PBMCs in 
these experiments. Keadle (123) reportedly tested the response of equine PBMCs to 0.4S 
or 4.8 HA U of EIV. Some evidence suggests that immunological effects o f stress-related 
hormones may only be observed when the appropriate suboptimal dose o f mitogen is used 
(73).
Lastly, when the stimulation indices were calculated for ElV-specific and mitogen- 
induced lymphoproliferation measured in this experiment they were rather low. However, 
they were still in the acceptable range. Stimulation indices for Keadle’s (123) data are not 
known. Further work is needed to clarify effects o f various stressors on 
lymphoproliferation o f equine PBMCs.
A primary goal o f this experiment was to determine if there was a relationship 
between acute stress-induced changes in catecholamine secretion and in vitro 
lymphoproliferation. Results from this experiment indicate there is not a relationship 
between these two endpoints. However, results from in vitro experiments have 
demonstrated that lymphoproliferation may be altered by catecholamines (175, 176, 190, 
196). Denervation studies also clearly demonstrate an important effect o f catecholamines 
on various immune functions (21). Thus, it may be that circulating catecholamines are of
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little importance to acute changes in immune function and that long-term neurocrine 
actions are most important for adrenergic effects on immune cells.
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CHAPTER VI: CATECHOLAMINES MAY ACT THROUGH BETA 
ADRENERGIC RECEPTORS TO EFFECT LYMPHOPROLIFERATION OF 
EQUINE PERIPHERAL BLOOD MONONUCLEAR CELLS
A. Introduction
Multiple pathways o f communication between the neuroendocrine and immune 
systems have been described (6). Noradrenergic innervation o f primary and secondary 
lymphoid organs in humans, rats, and mice (21, 198) suggest that neural effects on the 
immune system are likely to be important in most species. Further, anatomical 
compartmentalization o f noradrenergic innervation in lymphoid organs has been suggested 
to reflect specific effects o f catecholamines (norepinephrine, epinephrine) on distinct 
immune cell types (37). Whether or not basal or stress-induced concentrations o f 
catecholamines consistently effect function o f the immune system in the equine species has 
not been determined.
Adrenergic receptors include alpha and beta classes. Alpha-adrenergic receptors 
are further classified into sub-types include alpha-1, alpha-2a, or alpha-2b. Beta- 
adrenergic receptors are classified into two sub-types which have been designated as beta- 
1 or beta-2. Each adrenergic receptor sub-type acts through a specific second messenger. 
Alpha-1 receptors elevate phospholipase C (PLC) and phospholipase A2 (PLA2) second 
messenger systems (199). Alpha-2a and 2b receptors reportedly decrease cAMP and C a" 
levels (199). Beta-1 receptors were reported to increase cAMP and C a" (25) whereas 
beta-2 receptor activation results in increased cAMP (25). Adrenergic receptors have
79
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been characterized on T and B lymphocytes (84, 200), macrophages (94), neutrophils 
(119), NK cell populations (201), leukocyte sub-sets (85), and CD4+ and CD8^ cells (93).
The effects o f catecholamines or aminergic agonists on equine influenza virus 
(EIV) specific- and pokeweed mitogen (PWM)-induced (non-specific) lymphoproliferation 
o f PBMCs were analyzed in this experiment. Results from the present study were 
expected to provide additional evidence for a direct effect o f catecholamines on equine 
immune cells. It was also hoped that results from this study would help to clarify types o f 
adrenoceptors which may be involved in catecholamine effects on the immune system in 
the equine species. Finally, these experiments tested for effects of catecholamines on EIV- 
specific lymphoproliferation.
B. Materials and Methods
1. Horses
Four horses were used for this experiment. Identity, care, and maintenance o f 
these horses were described in Chapter three.
2. Preparation of Compounds
Test compounds (Sigma Chemical Co., St. Louis, MO) included norepinephrine 
(NE, -arterenol), (+) epinephrine (E), methoxamine-HCl (M), and isoproterenol (I). 
Concentrations used in the experiment were 1C6, 1 O'9, and 10'12M forN E; 10"6, 10'*, 10'\ 
IQ-iu, jg-12, ancj io‘14m  for E; and 1C4, 1C6, and 10'8M for M and I. All compounds were 
weighed and stored in a dark air tight desiccated environment at -85° C until PBMCs were 
available for the in vitro experiments.
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3. Sample Collection and Lymphoproliferation Assays
Blood samples were collected from resting horses at 7:00 AM while the animals 
were on pasture. Sampling procedures were described in Chapter three. 
Lymphoproliferation assays evaluated alpha- and beta-adrenergic effects on EIV-induced 
and PWM-induced lymphoproliferation as described in Chapter three. Test compounds 
were dissolved in media at twice the final concentration. This was done just before the 
addition o f compounds to the cultures.
4. Statistical Analysis
All samples were assayed in quadruplicate and each assay was done once for each 
o f the four horses used for this experiment. Data were analyzed to determine the effects 
o f  amines and aminergic agonists on in vitro lymphoproliferation using one way analysis 
o f variance. Dunnett’s t-test was used for pairwise comparisons to determine if treatment 
with different concentrations o f each compound resulted in a significant difference as 
compared to results measured for the control.
C. Results
1. Effects o f Norepinephrine on Lymphoproliferation of PBMCs Cultured for 5
Days
EIV- and mitogen-induced lymphoproliferation were measured for cultures treated 
with three different concentrations o f norepinephrine. Lymphoproliferation was calculated 
as the stimulation index. Lymphoproliferation for control cultures stimulated with 1.6 HA 
U o f EIV (dose 1), 16 HA U of EIV (dose 2), and PWM (2 pg/ml media) were 3.05 ±
0.89, 3.98 ± 0.04, and 5.88 ± 0.62, respectively (Figure 10). Proliferative response of
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AMINE CONCENTRATION
Figure 10: Effects of norepinephrine (NE) on lymphoproliferation of PBMCs 
cultured for 5 days. Influenza-specific and mitogen-induced lymphoproliferative 
responses were measured for cells collected from resting horses (n=4) and treated with 
mitogen or mitogen and three different concentrations o f norepinephrine. Cultures were 
incubated with two doses of EIV [dose 1 (1.6 HA U); dose 2 (16 HA U)] or one dose of 
PWM (2 pg/ml). Lymphoproliferation was calculated as the stimulation index for mitogen 
plus media controls ( c ) or for cultures which were incubated with mitogen and I O'12, 10'9, 
or I O'6 M NE. Background cpm were 18038, 12262, 17996, and 17512 for PBMCs 
cultured only with media, or with I O'6, 10'9, and 10'12 M NE in media, respectively. Data 
were analyzed by one way ANOVA and means for each treatment group were compared 
to the control using Dunnett’s t-test. Means (± SE) that were significantly different 
(P<0.05) from the controls were marked with an asterisk (*).
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control cultures treated with mitogens was low but acceptable since stimulation indices 
were greater than 2.
Mitogen-induced lymphoproliferation was stimulated (P<0.05) when PBMCs were 
cultured with 10'12 M NE (13.93 ± 1.85). At 10'9 and I O'* M doses of NE there was no 
significant effect on mitogen-induced lymphoproliferation. Influenza-specific 
lymphoblastogenesis was also not effected (P>0.05) by NE treatments.
2. Effects o f  Epinephrine on Lymphoproliferation o f PBMCs Cultured for 5
Days
Influenza-specific and mitogen-induced lymphoproliferation were measured for 
cultures treated with five different concentrations o f  epinephrine (Figure 11). Stimulation 
indices for control cultures were 2.79 ± 0.79, 3.13 ± 0.62, and 4.48 ± 0.69 for EIV dose 
1, EIV dose 2, and PWM-treated cultures, respectively. There were no significant effects 
of E treatment on ElV-specific and mitogen-induced proliferative responses.
3. Effects o f  Alpha-Adrenergic Agonist on Lymphoproliferation o f PBMCs 
Cultured for 5 days
The alpha-adrenergic agonist used in this experiment was methoxamine which is 
specific for the alpha-1-adrenergic receptor class (84). Influenza-specific and mitogen- 
induced proliferation were not effected (P>0.05) by any dose o f M (Figure 12).
4. Effects o f  Beta-Adrenergic Agonist on Lymphoproliferation o f PBMCs 
Cultured for 5 Days
Isoproterenol was used as the beta-adrenergic agonist in these experiments. This 
compound may act through both beta-1 and beta-2 adrenoceptors (84). Stimulation 
indices were 2.79 ± 0.79 and 3.13 ± 0.62 for control cultures treated with ElV-dose 1 and
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Figure 11: Effects of epinephrine (E) on lymphoproliferation of PBMCs cultured 
for 5 days. Influenza-specific and mitogen-induced lymphoproliferation were measured 
for cells collected from resting horses (n=4) and treated with five different concentrations 
of E. Cultures were incubated with two doses o f EIV [dose I (1.6 HA U); dose 2 (16 
HA U)], or one dose of PWM (2 pg/ml). Lymphoproliferation was calculated as the 
stimulation index for media controls (c ) or for cultures which were incubated with 
mitogen and 10"u , 10'a , 10'10, 10‘9, or 10"6 M E. Background cpm for PBMCs cultured 
only with E or media were 18038 (media), 13995 (lO^M E), 12631 (10-9M E), 11680 
(10'1°M E), 12271 (10*I2M E), and 14843 (10'14M E). Data were analyzed by one way 
ANOVA and means for each treatment group were compared to the control using 
Dunnett’s t-test. There were no significant effects o f E on EIV- or mitogen-induced 
proliferative responses.
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Figure 12: Effects of alpha-adrenergic agonist on Iymphoproliferation of PBMCs 
cultured for 5 days. Influenza-specific and mitogen-induced Iymphoproliferation were 
measured for cells collected from resting horses (n=4) and treated with mitogen or 
mitogen plus three different concentrations o f methoxamine. Cultures were incubated 
with two doses o f EIV [dose I (1.6 HA U); dose 2 (1 6  HA U)] or one dose of PWM (2 
pg/ml). Lymphoproliferation was calculated as the stimulation index (mean ± SE) for 
media controls with mitogen (c ) and mitogen-treated PBMCs that were incubated with 
10‘s, I O'6, or 10-4 M methoxamine. Background cpm for PBMCs cultured in media or 
media with methoxamine were 18038, 20950, 15736, and 19243 for media, 10"4, I O'6, and 
10'8M M, respectively. Data were analyzed by one way ANOVA. Methoxamine 
treatments did not effect (P>0.05) specific and non-specific lymphoproliferation measured 
in these assays.
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ElV-dose 2 (Figure 13). Stimulation indices for ElV-dose 1-treated cultures were not 
significantly different from the control when PBMCs were incubated with isoproterenoi. 
Stimulation indices for ElV-dose 2 cultures treated with isoproterenol were also not 
significantly different from the control stimulation index.
The stimulation index for control cultures treated with PWM was 4.48 ± 0.69. 
Stimulation indices for PWM-treated cultures incubated with I O'" and I O'6 M 
concentrations o f isoproterenol were not significantly different from the stimulation index 
for control cultures. Lymphoproliferation for PWM-treated control cultures was lower 
(P<0.05) than that measured for PBMCs incubated with PWM and 10~*M isoproterenol 
(11.23 ±2.13).
D. Discussion
Certain physiological and pathological conditions can elicit neurotransmitter 
release in the proximity o f immunoproficient cells (202). Consequently, neurotransmitters 
may effect cellular, metabolic, and functional processes by binding to various classes of 
membrane receptors. Catecholamines have been reported to act on the immune system in 
nanomolar concentrations through neurotransmitter and paracrine modes. Acute 
sympathetic activation resulting from exercise bouts or psychological stress causes a 
selective increase in circulating NK (CD56') cells that are rich in P-adrenergic receptors 
(85). Results from the same laboratory indicated that the effects o f stressors on bfK cells 
could be mimicked by intravenous infusion o f epinephrine (85). However, in vitro 
experiments have suggested that P-adrenergic receptor activation results in 
immunosuppression (90, 203) and that epinephrine acts through this receptor class to
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AGONIST CONCENTRATION
Figure 13: Effects of beta-adrenergic agonist on Iymphoproliferation of PBMCs
cultured for 5 days. Influenza-specific and mitogen-induced lymphoproliferative 
responses were measured for ceils collected from resting horses (n=4) and treated with 
mitogen (c ) or mitogen plus three different concentrations of isoproterenol. Cultures 
were incubated with two doses of EIV [dose 1 (1.6 HA U); dose 2 (16 HA U)] or one 
dose of PWM (2 ug/ml). Lymphoproliferation was calculated as the stimulation index 
(mean = SE) for media controls incubated with mitogen and mitogen-treated cultures that 
were incubated with 10'®, I O'0, or IQ"1 M isoproterenol. Background cpm for PBMCs 
cultured with I were 18038, 11521, 15598, and 18398 for cells cultured only in media, or 
with 10"\ 10", and 10'8 M I in media, respectively. Data were analyzed by one way 
ANOVA and means for each treatment group were compared to the control using 
Dunnett’s t-test. Significant differences (P<0.05) as compared to the control were marked 
with an asterisk (*).
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suppress NK cell activity in humans (201). Results from this experiment demonstrated 
that norepinephrine and isoproterenol elevated PWM-induced lymphoblastogenesis. 
However isoproterenol did not effect ElV-induced proliferation o f PBMCs.
The role o f alpha-adrenoceptor stimulation in lymphocyte activation is not clear. 
Recent findings suggest that alpha-1, alpha-2a, and alpha-2b adrenoceptors play a 
modulatory role in the lymphocyte response (90, 203). Catecholamines enhanced 
proliferation o fC D 3 \ C D 4\ and CD8+ lymphocytes by a-adrenergic stimulation whereas 
P-adrenergic stimulation inhibits proliferation of human lymphocytes (84). These effects 
were more pronounced for CD8" lymphocytes than for CD4' cells (93). Results from this 
experiment indicate that low concentrations of NE stimulate PWM-induced growth. 
However, the alpha-1 agonist did not effect lymphoproliferation. Keadle (123) reported 
that PWM-induced lymphoblastogenesis was inhibited by NE or E when PBMCs were 
collected from unconditioned horses. Methoxamine and isoproterenol depressed PWM- 
induced lymphoproliferation of PBMCs from unconditioned horses (123). Mitogen- 
induced lymphoproliferation of PBMCs from conditioned horses was stimulated by low 
concentrations o f isoproterenol (123). There is evidence that lymphocyte responses may 
be positive or negative depending on the prevalence of alpha or beta receptors (93). 
Whether agonists that act on a receptor subtype that we did not test for could help to 
account for stimulatory or inhibitory effects of amines on non-specific proliferation 
requires further study.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
CHAPTER VH: RELATIONSHIP BETWEEN EXERCISE STRESS-INDUCED 
CHANGES IN LYMPHOPROLIFERATION AND CIRCULATING 
CORTISOL CONCENTRATIONS IN PONIES
A. Introduction
Stressful events may result in development and progression of a variety o f medical 
disorders. Physical exertion or intense exercise stress may have detrimental effects on 
nearly all organ systems o f the body. Response to a single bout o f exercise is generally 
short lived whereas repetitive training programs that involve intense exercise may produce 
various long-term changes in immune function and susceptibility to disease (108).
In human and equine research models, the amount o f cortisol liberated depends not 
only on intensity and duration of exercise but also on the athlete's training state (123,
182). Results from chronic stress models have shown a slight decrease in cortisol 
secretion rather than an increase (22). These results confirm earlier findings showing that 
chronic stress, in contrast with acute stress, may not augment cortisol secretion (204,
205). It has also been reported that chronic social stress leads to a prolonged increases in 
cortisol secretion without impaired immune function (22). These observations do not 
eliminate an immunomodulatory role for cortisol in chronic exercise stress (52).
This set o f experiments was designed to monitor the release o f stress hormones 
over time in relation to ElV-specific and mitogen-induced lymphoproliferation.
B. Materials and Methods
1. Ponies
Eight unconditioned ovariectomized ponies, two to four years of age, were used 
for this experiment. They were not halter trained or regularly handled prior to being
89
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
90
assigned to the project. Handling they received prior to this project was limited to 
required vaccinations, regular deworming, and farrier work. All ponies were maintained 
on pasture before they were assigned to this study. At the start o f  the project, ponies were 
housed two per box stall and they were fed 8 quarts o f Omalene pellets at 8:00 AM and 
4:00 PM. Water was supplied ad-libitum. They were ovariectomized approximately 4 
weeks before the beginning o f the experiments. All ponies were vaccinated 
intramuscularly with a commercially available influenza virus vaccine in May of 1994.
Each pony received 2 doses o f inactivated influenza vaccine (influenza A/equine/H3N8, 
influenza A/equine/H7N7), 14 days apart, per label instructions (Fort Dodge, IA).
Ponies were randomly divided into two groups. Four o f the ponies were 
maintained as a control group and the remaining ponies were assigned to the stressed 
group. Experiments included three separate acclimation periods and various stress tests. 
Stress tests, vaccination, and acclimation periods were performed on the dates listed in 
Table 6.
2. Stress Test Regimes
Ponies were acclimated to the treadmill, rested, and subjected to the stress tests on 
the dates listed in Table 6. Details o f these experimental manipulations are described 
below.
a. Acclimation periods. There were four separate acclimation periods, 
which were designated acclimation-I, -Ila, -lib, and -EH. The control group was subjected 
to acclimation-I, -Ila, and -lib whereas the stressed group was subjected to acclimation-I, 
-Ila, and -III. During acclimation-I, ponies were walked for 5 to 10 minutes on the
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Table 6: Dates for Vaccination, Stress Tests, and Acclimation Periods
Control ponies Stressed ponies
Vaccination (5/94) X X
Baseline endpoint measurement (5/30/94) X X
Acclimation-I (6/1/94 - 6/19/94) X X
Minimal exercise stress test (6/20,21/94) X X
Acclimation-IIa (6/22,23/94) X X
Resting period (6/24/94 - 6/26/94) X
Acclimation-IIb (6/27/94 - 11/11/94) X
Slow gallop/moderate exercise stress (6/27,28/94) X
AccIimation-III (6/29/94 - 7/6/94; 7/9/94 - 7/14/94) X
Fast gallop/intense exercise stress (7/7,8/94) X
Procedures are listed in the order that they were performed. Boxes with an x indicate that 
a particular group was subjected to a procedure. A blank box indicates that the group was 
not included in that part o f  the experiment. Ovariectomy was performed by a licensed 
veterinarian approximately 4 weeks before the stress tests were started.
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treadmill at 1.4 meters/second (m/s) for 19 days. This was followed by acclimation-IIa 
which included a 4 minute walk at 1.2 m/s, a 4 minute trot at 2.0 m/s, and finally a 5 
minute walk at 1.2 m/s for 2 days. Ponies were rested for 3 to 4 days prior to the day of 
the minimal exercise stress test. After the minimal exercise test, all ponies were 
maintained on the acclimation-IIa protocol for 2 days. Control animals were subsequently 
maintained for approximately 5 months on the acclimation-IIb protocol which consisted of 
treadmill exercise identical to that described for acclimation-IIa.
Ponies in the stressed group were rested for 3 to 4 days prior to the slow 
gallop/moderate exercise stress test. After the moderate exercise stress test, ponies in the 
stressed group were subjected to the acclimation-HI protocol where they walked for thirty 
seconds at 1.2 m/s, trotted for 1 to 1.5 minutes at 2.5 m/s, and galloped for 3 to 4 minutes 
at 6.5 to 7.5 m/s. Then they galloped for 4 minutes at 7.0 to 7.5 m/s on a 6% or 7% 
incline, trotted for 2 minutes at 2.5 m/s, and finally walked for 4 minutes at 12 m/s.
Ponies were maintained on the acclimation-HI protocol for 10 days.
b. Stress tests. The tests included a minimal exercise stress, slow 
gallop/moderate exercise stress, and a fast gallop/intense exercise stress. The minimal 
exercise stress test utilized a protocol where ponies in both groups (n=8) walked on the 
treadmill for 25 minutes at 1.2 m/s. The minimal exercise stress test was done to 
determine whether endocrine and/or immunological parameters would be modified by low- 
level physical exertion. The test was started at 7:00 AM and it ended at 11:00 AM when 
the last sample was collected from the last pony. Two control and 2 stressed group 
animals were tested per day so that it took 2 days to complete this test.
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Ponies in the stressed group completed the slow gallop/moderate exercise stress 
test. This test included a 1.0 minute walk at 1.2 m/s, a 2.0 minute trot at 2.5 m/'s, an 8.0 
minute gallop at 6.5 to 7.5 m/s, a 5.0 minute gallop at 8 m/s, a 2.0 minute trot at 2.5 m/s, 
and a 1.0 minute walk at 1.2 m/s. This test was done to determine whether moderate 
physical exertion had an effect on endocrine and/or immunological endpoints included in 
this study. The slow gallop/moderate exercise stress test was started at 7:00 AM and 
ended when the last sample was collected. Two ponies were tested per day so it took 2 
days to complete this stress test.
Finally, a fast gallop/intense exercise stress was performed where the stressed 
group ponies were walked for I minute at 1.2 m/s, followed by a 2 minute trot at 2.5 m/s, 
a 1 minute gallop at 7.0 m/s on a 6% incline, a 7 minute gallop at 7.0 m/s on a 7% incline, 
a trot for 2 minutes at 2.5 m/s, and a 12 minute walk at 1.2 m/s. The fast gallop/intense 
exercise stress test was performed to determine whether intense physical exercise effected 
our experimental endpoints. This test was started at 7:00 AM and ended when the final 
sample was collected from the last pony around 10:00 AM on each day o f  the test. Two 
ponies were tested per day and the test was done on two consecutive days.
Pre-test handling was the same for all ponies. Ovariectomized ponies were 
catheterized through the jugular vein between 3:30 and 4:30 PM on the day before the 
start o f each stress test. Catheters were flushed using physiological saline (0.9% NaCl) at 
10:30 PM on the same day. On the day of the stress test, food and water were withheld 
until the last sample was collected.
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Each pony spent about 25 minutes on the treadmill during the exercise stress tests. 
All ponies were cooled down about 15 minutes after they got off the treadmill.
3. Sample Collection and Analysis
Baseline endocrine and lymphoproliferation data were collected at the beginning of 
the project. Blood samples were collected from resting ponies to measure baseline 
circulating cortisol concentrations. Five samples were collected at 15 minutes intervals. 
Radioimmunoassay (RIA) was used to measure cortisol concentrations in plasma samples. 
A single blood sample was collected at the same time in order to measure equine influenza 
virus (ElV)-specific and mitogen-induced lymphoproliferation.
Blood samples for cortisol RIA were collected one hour prior to the beginning of 
each stress test, at the beginning o f the stress tests, and at 5, 10, 15, 20, 25, 30, 45, 60, 
and 120 minutes after the start o f each stress test. A recently validated HPLC method 
(Chapter three) was used to analyze circulating concentrations o f epinephrine and 
norepinephrine in samples collected one hour prior to the beginning o f each stress test, at 
the beginning of the stress tests, and at 5, 10, 15, 30, 45, 60, and 120 minutes after the 
start o f each stress test.
Assays for EIV-, phytohaemagglutinin (PHA)-, and pokeweed mitogen (PWM)- 
induced lymphoproliferation were performed as described in Chapter three using PBMCs 
collected at four time points. Samples were collected 60 minutes before (T^0) each stress 
test and at 13 (TM3), 33 (T„33), and 73 (T ,73) minutes after the start o f each stress test.
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4. Statistical Analysis
All samples were analyzed in triplicate or quadripulicate. Data were analyzed 
using repeated measure ANOVA to determine the effect o f  stress on circulating cortisol 
concentrations, ElV-specific proliferation, and mitogen-specific lymphoproliferation. 
Spearman and Pearson methods o f statistical correlation were performed to determine the 
relationship between circulating cortisol concentrations and lymphoproliferation. Pairwise 
comparisons were made using Tukey’s t test in order to identify significant differences in 
specific or non-specific lymphoproliferation and circulating cortisol concentrations within 
and between the two groups o f animals.
C. Results
1. Baseline Cortisol Concentrations and ElV-specific and Mitogen-induced 
Lymphoproliferation
Cortisol concentrations are listed in ng/ml (mean ± SE) for the samples collected 
from resting ponies (Table 7). The mean baseline cortisol concentration was 1355.08 
ng/ml. There was no effect (P>0.05) of time on cortisol concentrations.
Table 8 lists results for EIV-induced lymphoproliferation (mean ± SE) assays. The 
EIV dose 1 treatment did not result in an acceptable stimulation index.
Lymphoproliferation induced by EIV dose 2 was 5.85 ± 1.84. Non-specific 
lymphoproliferation induced by PHA and PWM was 108.93 ± 12.67 and 123.64 ± 12.65, 
respectively.
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Table 7: Cortisol Concentrations in Resting Ponies
Time (minutes) Cortisol (ng/ml)
Mean ± SE
0 1471.69 ± 148.69
15 1476.64 ± 152.41
30 1254.97 ± 67.27
45 1251.76 ± 191.63
60 1320.35 ± 199.67
Samples were collected from resting ponies starting at 8:00 AM and cortisol was 
measured using radioimmunoassay. There was no effect (P>0.05) of time on mean 
cortisol concentrations.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
97
Table 8: Lymphoproliferation of PBMCs Collected from Resting Ponies
Stimulation Indices (mean ± SC)
EIV (dosel) 0.38 ± 0 .1 1
EIV (dose2) 5.85 ± 1.84
PHA 108.93 ± 12.67
PWM 123.64 ± 12.65
Baseline ElV-specific and mitogen-induced lymphoproliferative responses were 
determined using four resting ponies. Influenza-specific [EIV dose 1 (1.6 HA U); EIV 
dose 2(16 HA U)] Iymphoproliferation was measured after PBMCs were cultured for 5 
days and mitogen-induced lymphoproliferation was measured on day 3 using 2 pg/ml of 
PHA or PWM.
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2. Effect o f Minimal Exercise Stress on Circulating Cortisol Concentrations and 
Lymphoproliferation
Cortisol concentrations in samples collected before, during, and after the minimal 
exercise stress test are listed in Table 9. There was no change (P>0.05) in cortisol 
concentrations throughout this stress test.
Table 10 lists EIV dose 2-, PHA-, and PWM-induced lymphoproliferation results 
for samples collected at the four different time points described in materials and methods. 
There were no significant effect o f minimal exercise stress on lymphoproliferation. This 
was true for both ElV-specific and mitogen-induced lymphoproliferation.
3. Effect o f slow gallop/moderate exercise stress on circulating cortisol 
concentrations and lymphoproliferation
Table 11 shows cortisol concentrations for samples collected at eleven different 
time points. Cortisol concentrations measured in samples collected one hour before the 
test and at the beginning o f the stress test were 2276.08 ± 217.01 and 1857.56 ± 141.22 
ng/ml, respectively. Cortisol concentrations measured in samples collected at 5, 10, 15,
20, 25, 30, 45, and 60 minutes after the start o f the stress test were decreased (P<0.05) as 
compared to the concentrations observed one hour before and at the beginning o f the 
stress test. Cortisol concentrations in samples collected 120 minutes after the start of the 
stress test were not significantly different from hormone concentration measured before 
the test.
Results for ElV-specific and mitogen-induced lymphoproliferation of PBMCs 
collected during the slow gallop/moderate exercise stress test are listed in Table 12. There 
was no significant effect o f time on ElV-specific or mitogen-induced lymphoproliferation.
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Table 9: Cortisol Concentrations in Ponies Exposed to Minimal Exercise Stress
Conditions of the 
Test
Time (minutes) Cortisol Concentrations 
(ng/ml)
Stalled
o•~o1 1950.54 ± 134.15
T readmill/standing 0 2068.55 ±70.81
Walk 5 1925.96 ±85.15
Walk 10 2022.84 ± 166.74
Walk 15 1963.02 ± 177.47
Walk 20 1995.74 ± 154.69
Walk 25 2119.21 ± 138.87
Treadmill room 30 1881.53 ± 167.75
Treadmill room 45 2099.41 ±206.86
Stalled 60 2220.47 ± 173.41
Stalled 120 2168.49 ±202.76
Cortisol concentrations in ng/ml (mean ± SE) were determined for samples collected one 
hour before the beginning o f the stress test (-60), at the beginning o f the stress test (0), 
and at 5, 10, 15, 20, 25, 30, 45, 60, and 120 minutes after the start o f the stress test (n=4). 
Cortisol was measured using radioimmunoassay. Data were analyzed by ANOVA. There 
was no (P>0.05) main effect of time on plasma cortisol concentrations.
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Table 10: ElV-specific and Mitogen-induced Lymphoproliferation of PBMCs 
Collected from Ponies Exposed to Minimal Exercise Stress
T re a tm e n t S tim u la tion  Ind ices  (m ean  ±  SE)
T^o T„3 T-33 T.-3
EIV(dosc2) 3.92 ±  1.89 4.61 ±  1.85 3.45 ± 0 .9 9 3.60 ±  1.53
PHA 26.43 ± 8 .1 1 34.60 ±  9.34 35.47 ±  11.96 49.64 ± 2 3 .6 7
PW M 55.73 ±  15.01 68.95 ±  16.32 65.02 ±  13.60 61.53 ± 2 0 .1 7
Influenza-specific lymphoproliferation was measured on day 5 using 16 HA U of EIV 
(dose 2). Mitogen-induced lymphoproliferation, measured on day 3, was tested with 2 
pg/ml o f PHA or PWM. Lymphoproliferative responses are listed as stimulation indices 
(mean ± SE) for samples collected one hour prior (T^0) to the beginning of the stress test 
and at 13 (T ,13), 33 (T_33), and 73 minutes (T ,73) after the beginning o f the stress test. 
Background media cpm for the EIV culture plates were 180.62, 316.08, 116.88, and 
159.00 for samples collected at T.#), T̂ 13> T*33, and T .73, respectively. Background cpm 
for PHA and PWM cultures were 127.48, 139.75, 89.16, and 86.70 for samples collected 
at T^0, T .13, T ,33, and T ,73, respectively. Data were analyzed by repeated measures 
ANOVA. Stress did not significantly effect ElV-specific or mitogen-induced 
blastogenesis.
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Table 11: Cortisol Concentrations in Ponies Exposed to Slow Gallop/Moderate
Exercise Stress
Conditions of the 
Test
Time (minutes) Cortisol Concentrations 
(ng/ml)
Stalled -60 2276.08 ±217.01
T readmill/standing 0 1857.56 ± 141.22
Trot 5 1209.91 ± 193.13*,s
Gallop 10 907.44 ± 11 l.84*,s
Gallop/incline 15 886.65 ± 165.41*-s
Trot 20 816.72 ± 88.43* s
Walk 25 707.77 ± 89.80*,s
Treadmill room 30 892.83 ± 59.39* s
Treadmill room 45 1181.16 ± 125.25*s
Stalled 60 1337.30 ± 145.72* s
Stalled 120 2018.78 ± 191.13
Circulating cortisol concentrations are listed in ng/ml (mean ± SE) for samples collected 
one hour prior to the beginning o f the stress test, at the beginning of the stress test, and at 
5, 10, 15, 20, 25, 30, 45, 60, and 120 minutes after the start of the stress test (n=4). 
Significant differences between stress-induced cortisol concentrations and hormone 
concentrations in the -60 sample are marked with an asterisk (*). Significant differences 
as compared to the 0 time point are marked with a dollar sign ($).
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Table 12: ElV-speciflc and Mitogen-induced Lymphoproliferation in Ponies 
Exposed to Slow Gallop/Moderate Exercise Stress
Treatment Stimulation Indices (mean ± SE)
T.«) T+,3 T-33 T.73
EIV(dose2) 5.79 ± 2.50 8.08 ± 3.62 5.21 ±2.65 6.79 ± 1.00
PHA 28.05 ± 11.57 35.44 ± 9.45 22.83 ±7.21 86.28 ±32.57
PWM 49.73 ± 17.40 43.26 ± 18.18 38.97 ± 12.57 49.35 ± 10.75
Influenza-specific lymphoproliferation was measured on day 5 using 16 HA U of EIV. 
Mitogen-induced lymphoproliferation, measured on day 3, was tested with 2 pg/ml of 
PHA or PWM. Lymphoproliferation results are listed as stimulation indices (mean ± SE) 
for samples collected one hour prior (T^,) to the beginning o f the stress test and at 13 
(T ,13), 33 (T^33), and 73 minutes (T+73) after beginning o f the stress test. Background cpm 
for EIV culture plates were 252.09, 178.46, 733.57, and 260.93 for samples collected at 
T-6o> T+i3, T .33, and T .73, respectively. Media blanks for PHA or PWM plates were 86.55, 
73.15, 72.54, and 56.14 for each o f the consecutive time points. There were no significant 
effects o f stress on proliferative responses.
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4. Effect o f  Fast Gallop/Intense Exercise Stress on Circulating Cortisol 
Concentrations and Lymphoproliferation
Table 13 lists mean cortisol concentrations in ng/ml for plasma samples collected 
at 11 different time points starting one hour prior to the beginning o f the stress test. 
Cortisol concentrations decreased during the fast gallop/intense exercise stress test as in 
the slow gallop/moderate exercise stress test. Hormone concentrations measured in 
samples collected 10 minutes after the start o f  the fast gallop/intense exercise stress test 
were lower (P<0.05) than cortisol in the -60 and 0 minute samples. Cortisol 
concentrations in samples collected at the beginning and at 5, 60, and 120 minutes after 
the stress test started were significantly greater (P<0.05) than concentrations measured in 
samples collected one hour before the stress test started. Hormone concentrations 
measured in samples collected at the beginning o f the stress test were higher (P<0.05) than 
cortisol in samples collected one hour before, and at 10, 15, 20, 25, 30, and 45 minutes 
after the stress test started.
Table 14 summarizes results for ElV-specific and mitogen-induced 
Iymphoproliferation. The fast gallop exercise stress test did not effect (P>0.05) EIV- 
specific or mitogen-induced lymphoproliferation.
5. Quantitation of Catecholamines in Samples Collected During the Three 
Different Stress Tests
Samples were collected during the stress tests in order to measure amine 
concentrations at rest, during minimal exercise, moderate exercise, and intense exercise 
stress. Catecholamines were undetectable in all samples. This was likely due to 
equipment problems that occurred while the samples were in storage.
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Table 13: Cortisol Concentrations in Ponies Exposed to Fast Gallop/Intense Exercise
Stress
Conditions of the 
Test
Time (minutes) Cortisol Concentrations 
(ng/ml)
Stalled -60 1337.82 ± 417.96s
T readmill/standing 0 2476.99 ± 565.34*
Trot 5 2491.39 ±633.18*
Gallop 10 739.95 ± 33.5 l*-s
Gallop/incline 15 849.60 ± 158.70s
Trot 20 1196.75 ± 107.94s
Walk 25 1345.64 ± 182.33s
Treadmill room 30 1553.06 ± 109.16s
Treadmill room 45 1799.86 ± 121.82s
Stalled 60 2041.43 ± 192.18’
Stalled 120 2938.91 ±395.67*
This table lists circulating cortisol concentrations in ng/ml for samples collected one hour 
prior to the beginning o f the stress test, at the beginning o f the stress test, and at 5, 10, 15, 
20, 25, 30, 45, 60, and 120 minutes after the start o f the stress test (n=4). Significant 
differences between stress-induced cortisol concentrations and the -60 minute time point 
are marked with an asterisk (*). Significant differences as compared to the 0 time point 
are marked with a dollar sign ($).

















Table 14: ElV-specific and Mitogen-induced Lymphoproliferation in Ponies Exposed to the Fast Gallop/Intense
Exercise Stress
Treatm ent Stimulation Indices (mean ± SE)
t 60 T ,l3 T . 3 3 T ) 7 3
EIV(dose2) 21.00 ± 15.10 5.41 ±2,15 15.16 ± 7.36 16.04 ±7.69
PHA 86.24 ± 12.09 73.88 ± 14.99 72.96 ±22.22 105.09 ±47.99
PWM 133.09 ± 12.57 104.75 ± 12.24 122.11 ±36.98 154.07 ±44.42
Influenza-specific lymphoproliferation, measured on day 5, was tested using 16 HA U of EIV. Mitogen-induced 
lymphoproliferation, measured on day 3, was tested by incubating PBMCs with 2 pg/ml of PHA or PWM. Lymphoproliferative 
results are listed as stimulation indices (mean ± SE) for samples collected one hour prior (T 60) to the beginning of the stress test 
and at 13 (T ,13), 33 (T ,33), and 73 minutes (T ,73) after beginning the stress test. Background cpm for the EIV cultures were 
198.88, 257.30, 167.41, and 113.48 for the four consecutive time points. Media control cpm for PHA or PWM cultures were 
91.53, 83.23, 89.68, and 59.78 for samples collected at T 60, T tl3, T ,33, and T t73, respectively.
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6. Relationship o f Circulating Cortisol Concentrations to Lymphoproliferation of 
PBMCs Collected from Ponies
Circulating cortisol concentrations were not correlated (P>0.05) with EIV-, PHA-, 
or PWM-induced lymphoproliferation measured in minimal exercise, slow gallop exercise, 
and fast gallop exercise stress tests.
D. Discussion
The endocrine reaction to stress is very complex and only partially understood. As 
discussed in earlier chapters, the hypothalamus appears to play a central role in 
coordinating the endocrine, autonomic, and behavioral responses to stress. The 
hypothalamus exerts neural control over the two main axes involved in the stress response 
including the pituitary-adrenocortical and sympathetic-adrenomedullary axis.
This chapter dealt with changes in cortisol secretion in relation to exercise-induced 
lymphoproliferation in ponies. Evidence suggest that stress hormones act as mediators for 
exercise-induced changes in lymphoproliferation. It is also known that hormones, such as 
cortisol, influence leukocyte distribution in the circulation and various organs, including 
the spleen, and bone marrow (57).
While cortisol is frequently elevated in response to a variety o f stressors (99), 
plasma cortisol levels in ponies decreased during both the slow gallop/moderate exercise 
and fast gallop/intense exercise stress tests. This is in contrast to results for horses where 
cortisol concentrations increase in response to exercise stressors (73). In this regard, it 
should be noted that the adrenocortical response to stress is dependent on the individual 
perception o f the stress and an individuals prior history (204, 206, 207). Further, there is
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considerable individual variability in the glucocorticoid response to exercise stress. 
Individual differences in exercise capacity can result in large differences in stress- 
dependent changes in the hormone milieu (195). Very little, if any, research has been done 
on ponies in this regard, which makes it difficult to reconcile the differences between 
horses and ponies. However, the reader is reminded that these ponies were never 
regularly handled prior to the start o f the project. All o f the available literature for other 
species (204, 206, 207) suggests that the lack o f regular handling in the first few months 
after foaling resulted in long-term effects on the response o f adult ponies to regular 
exposure to the investigators. Results from this study suggest that handling the ponies 
during the project and the relatively unfamiliar housing conditions were more stressful 
than intense exercise. This possibility is supported by the high concentration o f cortisol 
measured in resting ponies and ponies subjected to the minimal exercise test. In the 
present experiment high cortisol concentrations were also measured at the beginning and 
the end of the moderate and intense exercise stress tests. In both o f the latter stress tests 
cortisol concentrations were significantly reduced when the animals started to gallop and 
they remained low until the exercise stress was close to being stopped. Clinically normal 
cortisol concentrations in ponies are 50-70 ng/ml (13, 133). Thus, cortisol concentrations 
in the ponies included in this project were persistently elevated.
In general, stress appears to down-regulate the immune response in humans. 
However, some hormones have been shown to have stimulatory effects on various 
functions of the immune system. As previously mentioned, one should keep in mind the
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type o f stress when interpreting results since different stressors elicit different profiles o f 
hormonal changes which in turn result in differential effects on the immune system.
Results from this study did not show significant differences in lymphoproliferation 
induced by any o f the stress tests. This could be the result of the elevated cortisol 
concentrations and chronic stress due to prior history o f the animals. It is also possible 
that high cortisol may have abolished acute effects o f exercise stress on 
lymphoproliferation.
It had been reported that there may be a high correlation between serum cortisol 
levels and changes in lymphocytes after exercise (175). Other studies have failed to find a 
relationship between serum cortisol and lymphocyte responses (208, 209). Studies 
showing a relationship between cortisol and lymphocyte function used intense endurance 
exercise models like marathon running in humans whereas studies that failed to show a 
correlation used shorter exercise bouts and unconditioned or less fit individuals. We did 
not observe a statistical correlation for cortisol and lymphoproliferation regardless of 
exercise intensity. Whether this was due to the nature and duration o f stressors that these 
ponies were exposed to is not known at the present time.
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CHAPTER VTH: SUMMARY AND PERSPECTIVES OF THOUGHT FOR
FUTURE RESEARCH
Stress may be associated with anaerobic metabolism, the release o f various 
hormones, activation o f the ANS, and altered function of the immune system. Coincident 
changes in neural, endocrine, and immune functions are thought to be the result of bi­
directional communication between the nervous and immune systems in humans (210,
211) and various animal models (204, 212).
Effects o f the CRF-ACTH-glucocorticoid/cortisol system on immune function are 
most widely accepted and studied. However, it is now clear that effects o f stress on 
immune function may also be independent o f glucocorticoids as stress related down- 
regulation of immune cell function can be demonstrated even in adrenalectomized and 
hypophysectomized rats (192). This research project was based on the assumption that 
catecholamines and cortisol probably account for most o f the effects o f exercise stress on 
equine immune function due to the prevalence o f adrenergic and cortisol receptors on or 
in many immune cell types.
This project also investigated the effects o f stress on equine influenza-specific 
lymphoproliferation. Equine influenza infections are prevalent and have a major impact on 
the economy of equine industry. Accordingly, the long term aim of this project was to 
determine whether preliminary data would indicate that pharmacological manipulations o f 
endogenous glucocorticoids and/or catecholamine might improve effectiveness of 
influenza vaccinations by increasing the magnitude and duration o f antibody titers that 
protect against influenza infections.
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Results from the experiments to quantitate cytosolic and nuclear GRs confirmed 
that equine PBMCs have receptors that are responsive to diurnal changes in hormone 
concentrations. It may be o f interest to determine cell types that have these receptors in 
order to begin to understand the significance of cortisol effects on equine PBMCs. 
Cytosolic GRs were low when cortisol concentrations peak in equine plasma. The highest 
nuclear and total binding was observed at 2 PM. This suggests that early morning 
increases in cortisol, and the related translocation o f GR to the nucleus, may stimulate GR 
synthesis. It is also likely to be related to glucocorticoid-dependent protein synthesis by 
equine PBMCs. Nuclear GR was not detectable at 2AM. This suggests that GR would 
not interfere with stimuli acting through cAMP and/or protein kinase C at that time point. 
Humoral compounds that act through these second messengers could be tested for in vitro 
effects on PBMCs collected at various time points o f the day. This might help to explain 
differences in the effects o f evening and morning stressor on immune functions.
In vitro ElV-specific and mitogen-induced lymphoproliferative responses o f 
PBMCs obtained from the samples collected at the beginning and during the various stress 
tests were enhanced, suppressed or unchanged. Significant increases in circulating 
catecholamine concentrations were measured in samples collected during slow gallop and 
fast gallop exercise stress tests. However, circulating concentrations of amines were not 
correlated with stress-induced changes in lymphoproliferation. Thus, the inhibition or 
stimulation of lymphocyte responses may depend on the number o f adrenoceptors on 
lymphocytes, the duration and type o f stress, and the duration o f time that cells are 
exposed to amines and other hormones.
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Research results from other species suggest that catecholamines may modulate 
equine lymphocyte function by acting through surface adrenergic receptors. The in vitro 
experimental results demonstrated that catecholamine-induced effects may be mediated by 
beta-agonists. Based on these results, lectin-induced lymphoproliferation may be sensitive 
to beta-adrenergic receptor activation. However, ElV-induced lymphoproliferation was 
not effected by in vitro treatments. It may be o f interest to test for in vitro effects o f other 
P-agonists and effects o f a-agonists that were not considered in these experiments. In 
vitro experiments with different types o f immune cells treated with catecholamine agonists 
and antagonists specific for different sub-types o f adrenoceptors may also help to elucidate 
mechanisms underlying catecholamine effects. This becomes particularly important when 
one considers factors such as the non-random distribution o f adrenergic receptors on 
various immune cells.
Other experiments were designed to investigate the effect of cortisol on equine 
immune function. Cortisol concentrations in all ponies were much greater than clinically 
normal concentrations. In exercise stressed ponies a significant decrease in the clinically 
abnormal cortisol concentrations was observed. Nevertheless, lowered cortisol in the 
exercise-stressed animals was still clinically abnormal. This suggests that prior history of 
the animals made the general experimental conditions more stressful than exercise. Other 
researchers have shown that early handling of newborn rats produces individuals that are 
better adapted to novel environments (204, 206, 207). Thus, it may be o f interest to 
perform epidemiological studies on the prior history o f horses that become infected with
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EIV after being stressed as adults. This could identify rearing strategies which might 
impact on economics o f the equine industry.
There were no significant differences observed in the lymphoproliferative 
responses in the different stress tests for ponies. Circulating concentrations o f cortisol 
were not correlated with either EIV- or mitogen-induced lymphoproliferation. Elevated 
basal levels o f cortisol might have made PBMCs refractory to acute fluctuations in cortisol 
concentrations.
Based on the available evidence, single bouts o f exercise may result in 
immunosuppressive or immunostimulation. Catecholamines and glucocorticoids may 
exert positive and negative effects on lymphocyte responsiveness following exercise. 
However, there are many potential modulators of the immune system that are released in 
response to various stressors. Results from this project suggest that compounds which 
produce the most pronounced effects on equine PBMCs in vitro should be measured in an 
experiment similar to the one that was done with the ponies that were used in this project.
Variations in endocrine and immune endpoints observed in these experiments may 
be attributed to differences in the stressors, individual differences in perception and 
response to stress, conditioning, immune processes, and differences in receptor 
distribution. Studies testing individual and combined actions o f various hormones and 
neurotransmitters systems are needed to understand the effects o f stress on immunity and 
disease processes. It would also be important to conduct studies using pure cultures of 
different immune cell sub-types in conjunction with studies on the effect o f various 
compounds on mixed cell cultures.
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It would be worthwhile to test combined effects o f catecholamines and 
glucocorticoids since they are likely to interact as part o f  their normal effects on immune 
cell fractions. For example, glucocorticoids and cAMP have been shown to synergistically 
activate transcription o f several genes in human and murine thymoma cells (213). On the 
other hand, the cAMP-mediated activation o f a-1 acid glycoprotein gene transcription is 
inhibited by glucocorticoids. Molecular studies on the mechanisms underlying these multi- 
hormonal effects on gene expression suggest an interaction between PKA-responsive 
transcription factors, most notably the CREB protein and GR (76, 77). The interaction of 
humoral factors might also be due to direct modulation o f GR function by PKA since 
hormone-dependent trans-activation o f GR in cells may be due, at least in part, to an 
increase in DNA binding activity o f GR (214). Results from other experiments indicate 
that increased steady state levels o f GR mRNA may be induced by cAMP analogues due 
to increased GR mRNA stability (77). In addition, in the presence o f glucocorticoids 
cAMP causes cytolysis o f murine lymphoma cells by increasing the level o f steroid binding 
(72). This dose-dependent glucocorticoid response was dependent upon the phenotype of 
the cAMP-dependent protein kinase (77).
In conclusion, many of the signals to the immune system from the nervous system 
are mediated, to some extent, by intracellular cyclic nucleotides and the responses vary 
according to the presence and abundance o f specific receptors. Molecular interactions of 
multiple signaling systems have been reported for steroid hormone and membrane signal 
transduction pathways which utilize protein kinases and other second messengers. The 
fact that this has been reported for diverse species and the direct in vitro effects o f
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catecholamines and glucocorticoids on equine immune cells suggests that similar 
interactions are likely to be important to veterinary medicine.
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